Understanding Young Adult Survivors of Childhood Cancers’ Participation in Late Effects Screening: A Mixed Methods Approach by Mantlo, Kristen Trost
Old Dominion University 
ODU Digital Commons 
Health Services Research Dissertations College of Health Sciences 
Fall 2019 
Understanding Young Adult Survivors of Childhood Cancers’ 
Participation in Late Effects Screening: A Mixed Methods 
Approach 
Kristen Trost Mantlo 
Old Dominion University, kristen.mantlo@gmail.com 
Follow this and additional works at: https://digitalcommons.odu.edu/healthservices_etds 
 Part of the Community Health and Preventive Medicine Commons, Health Services Research 
Commons, Oncology Commons, and the Public Health Education and Promotion Commons 
Recommended Citation 
Mantlo, Kristen T.. "Understanding Young Adult Survivors of Childhood Cancers’ Participation in Late 
Effects Screening: A Mixed Methods Approach" (2019). Doctor of Philosophy (PhD), Dissertation, , Old 
Dominion University, DOI: 10.25777/7asy-0q67 
https://digitalcommons.odu.edu/healthservices_etds/85 
This Dissertation is brought to you for free and open access by the College of Health Sciences at ODU Digital 
Commons. It has been accepted for inclusion in Health Services Research Dissertations by an authorized 




UNDERSTANDING YOUNG ADULT SURVIVORS OF CHILDHOOD CANCERS’ 




Kristen Trost Mantlo 
B.A May 2008, James Madison University 
B.S.W. December 2008, James Madison University 




A Dissertation Submitted to the Faculty of  
Old Dominion University in Partial Fulfillment of the  
Requirements for the Degree of  
 
DOCTOR OF PHILOSOPHY 
 
HEALTH SERVICES RESEARCH 
 








Richardean Benjamin (Director) 
 
 
Tina Gustin (Member)  
 
 
Hadiza Galadima (Member) 
 
 





UNDERSTANDING YOUNG ADULT SURVIVORS OF CHILDHOOD CANCERS’ 
PARTICIPATION IN LATE EFFECTS SCREENING: A MIXED METHOD APPROACH 
 
Kristen Trost Mantlo 
Old Dominion University, 2019 
Director: Dr. Richardean Benjamin 
 
 
 Significant advancements in the treatment of childhood cancers have helped to increase 
the 5-year survival rate from 56% in the early 1970s to approximately 80-85% in the early 2000s 
(Greenlee, Murray, Bolden, & Wingo, 2000; Hampton, 2005). Treatment modalities such as 
chemotherapy and radiation have led to many serious long-term side effects, known as late 
effects. Between 60% and 90% of survivors develop some form of long-term chronic condition 
due to their treatment and up to 40% of those conditions will be life-threatening (Howlader, N. et 
al., 2013).  While the majority of young adult survivors of childhood cancer are at risk for 
developing a late effect, most of them are not participating in recommended screening protocols 
to identify late effects (Schultz et al., 2010). Current research has identified individual patient 
characteristics associated with survivors’ screening practices but limited research has assessed 
the health beliefs of pediatric cancer survivors. The purpose of this study was to examine the 
factors that influence young adult survivors of childhood cancer participation in screening for 
late-effects.  
A mixed method’s design was used for this study. The quantitative portion in phase one 
used a modified version of Champion’s Health Belief Model (Champion’s Health Belief Model 
Scale). Participants could self-select to participate in the quantitative portion, followed by 
structured interviews analyzed using a grounded theory approach. Ninety-two participants were 
enrolled in phase one of the study, and 28 participants completed phase two, structured phone 
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interviews. Four models were assessed using Firth Logistic Regression. Findings showed three 
non-modifiable variables, age at time of survey (p<0.001), age greater than or equal 26 
(p=0.029), and time since last attending a late effects appointment (p=0.02) were associated with 
a survivor’s likelihood of attending a late effects appointment in the next year. Models showed a 
relationship between the modifiable factors of the health belief model, perceived self-efficacy 
(p=.029) and perceived threat (p=.043) with a young adult survivor’s likelihood of attending a 
late effects screening appointment in the next year. Phone interviews suggested that many of the 
constructs of health belief are present in a young adult survivor of childhood cancers’ health 
beliefs about late effects screening appointments. While the generalizability of this study is 
limited, it provides a starting point for understanding childhood cancer survivors’ health beliefs 
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In the United States, an increase in incidents of childhood cancer has occurred in the last 
22 years, from 15.7 cases per 100,000 children to 17.7 cases per 100,000 children (Howlader, et 
al., 2015). Improvements in the treatment of childhood cancer have enabled many childhood 
cancer patients to live well in to adulthood (American Academy of Pediatrics, 2009). 
Unfortunately, the majority of these childhood cancer survivors develop at least one long-term 
side effect, known as a late effect, from their initial cancer treatment (Howlader, et al., 2013). 
Chapter One will discuss the prevalence of childhood cancer, what childhood cancer is, 
and how it is treated, what late effects are and the types of late effects, the impact of late effects, 
the importance of screening for late effects, and what researchers know about childhood cancer 
survivors participation in screening for late effects. The end of Chapter One presents the purpose 
of the study, the research questions asked, definition of terms used throughout the body of this 
work, an introduction to the theoretical framework upon which the study was built, and the 
importance of the study.  
Background  
According to estimates from the National Cancer Institute (2014), more than 15,780 
children between the ages of 0 -19 were diagnosed with cancer in 2014. The number of 
diagnoses is steadily increasing at a rate of 0.6% each year (Smith, et. al., 2010). Approximately 
one in 300 boys and one in 333 girls are diagnosed annually (Howlader, et al., 2009). Compared 
to white children, African American children have a 28% reduced risk of developing a childhood 
cancer and Asian, and Hispanic children have a 15.5% reduced risk (Chow, et al., 2010). While 
childhood cancer is rare, it is the second leading cause of death for children who have lived past 
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infancy (National Cancer Institute, 2014). Yet the prognosis for childhood cancer patients is 
improving. Surveillance Epidemiology and End Results Program (SEER) estimates that there are 
currently 328,652 adult survivors of childhood cancer in the United States, which comprises 
0.1% of the adult population. (Maeda, 2009; Mariotto et al., 2009).  
Childhood Cancer 
Cancer is a term used to describe multiple diseases in which mutated cells divide in an 
uncontrolled manner and invade the surrounding tissues and organs rapidly and without 
restriction (NCI, 2015). These cells take advantage of the immune system to survive and 
continue to replicate and invade healthy portions of the body. Childhood cancers differ from 
adult cancers in the types of cancer, drugs used for treatment, and even how patients respond to 
treatment both short and long-term. Unlike most adult cancers, which are caused by mutations of 
genes associated with exposure factors such as ultraviolet (UV) light, asbestos, tobacco or other 
carcinogens, most childhood cancers stem from genetic mutation in a child’s DNA early in life 
often before birth (American Cancer Society, 2016). Less than five percent of childhood cancers 
are cause by inherited gene mutations (National Cancer Institute, 2014).  
There are 12 common types of childhood cancers of which, leukemia (blood cancer) and 
tumors are the most common with acute lymphoblastic leukemia (ALL) and brain tumors being 
the most common of the two respectively (Howlader, et al., 2013). Of the children diagnosed 
with cancer each year, one out of five is expected to die within the first five years of their 
diagnosis (Howlader, et al., 2013). However, the prognosis for childhood cancer patients is 
improving. Over the last 20 years, the five-year survival rate for childhood cancer patients has 
dramatically increased from nearly incurable to over 80% (Maede, 2008). The increase in 
survival rate has been attributed to improvements in how childhood cancer is treated. 
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Childhood Cancer Treatment 
 Most childhood cancer patients are treated at a childhood cancer facility or hospital 
associated with the Children’s Oncology Group (COG) supported by the National Cancer 
Institute.  COG is the largest organization in the world dedicated to treating childhood cancer; 
facilities associated with COG must meet strict standards for treatment and care (NCI, 2015). 
Childhood cancer treatment modalities vary based on diagnosis, but for children the most 
common forms consist of either one or more of the following modalities; surgery, chemotherapy, 
radiation therapy, and stem cell transplants (American Cancer Society, 2016). 
 Surgery is predominately used to remove solid tumors from a specific location, but can 
also be used to de-bulk/reduce the size of a tumor if removal is not possible due to risks, or to 
alleviate symptoms associated with the cancer  (NCI, 2015). Surgery is most often used in 
conjunction with another form of treatment such as chemotherapy or radiation therapy. 
 Chemotherapy also referred to as “chemo,” is a series or combination of drugs used to 
treat or alleviate symptoms of cancer (NCI, 2015). The specific drugs used for chemotherapy, the 
amount, and quantity of doses a patient receives depends on the specific type of cancer a patient 
is diagnosed with. Since childhood cancers differ from adult cancers the types of chemotherapies 
used, the dosage levels, and frequencies differ from those used to treat adult cancers.  
Chemotherapy is used to attack fast growing cells, however in children, all cells are fast 
growing, so chemotherapy often kills both the cancerous cells as well as other cells in the body 
including those of the immune system (NCI, 2015).  Chemotherapy can have a number of 
immediate side effects such as low blood counts; nausea, hair loss, diarrhea, these and other 
immediate side effects depend on the type and strength of chemotherapy. Chemotherapy can be 
used alone or in conjunction with surgery or radiation therapy (NCI, 2015).  
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 Radiation therapy is another treatment modality that can be used alone, or in conjunction 
with another form of cancer treatment. Radiation can slow or terminate a cell’s growth, including 
both cancer and neighboring tissue or organ cells. External radiation is used to address a targeted 
area, while internal radiation is given intravenously and seeks out cancer cells internally (NCI, 
2015). The type of radiation and location impacts the types and intensity of side effects cancer 
patients experience from fatigue to infertility.  
 Stem cell transplants are used in conjunction with either chemotherapy or radiation 
therapy. Chemo or radiation is used in high doses to eliminate cancerous cells as well as healthy 
cells. Stem cells are then transplanted to combat cancerous cells, or to help build red and white 
blood cells, so that they can help a patient recover from chemo or radiation therapy (NCI, 2015).  
Childhood Cancer Survivorship 
An individual is considered a childhood cancer survivor from the time they are diagnosed 
with cancer until the end of their life (NCI, 2015). For childhood cancer patients a new term, 
long-term cancer survivor, is being used to distinguish survivors who are five years post final 
cancer treatment and those who are recently diagnosed or being treated. Survivorship is filled 
with a variety of new changes for a childhood cancer survivor and their family, including 
excitement around completing treatment, developing a new sense of what “normal” life is like, 
and navigating aspects of long term follow-up care as well as the necessary screenings to 
monitor for late effects.  
Late Effects 
 Treatment of cancer can cause immediate side effects such as low blood cell counts, hair 
loss, nausea, diarrhea, or other complications, but it can also cause side effects that develop well 
after the initial treatment phase. Late effects, defined by the National Cancer Institute as, “a 
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health problem that occurs months or years after a disease is diagnosed or after treatment has 
ended” and have serious effects on the health of survivors (2016). For childhood cancer patients 
it is extremely important to be aware of the late effects associated with the modalities used to 
treat the cancer patient’s initial diagnosis.  
Statement of the Problem 
Significant advancements in the treatment of childhood cancers have helped to increase 
the five-year survival rate from 56% in the early 1970s to approximately 80-85% in the early 
2000s (Greenlee, Murray, Bolden, & Wingo, 2000; Hampton, 2005). It is estimated that there are 
currently 380,000 childhood cancer survivors in the United States, which is approximately 1 in 
1,000 adults (Ward, DeSantis, Robbins, Kohler, & Jemal, 2014). As the number of childhood 
cancer survivors continues to increase, physicians and researchers have been able to study and 
identify the varying impacts cancer treatment has on the health of childhood cancer survivors. 
The majority of childhood cancer survivors (60% to 90%) will develop some form of long-term 
chronic condition due to their treatment and up to 40% of these late effects will be life-
threatening (Howlader, et al., 2013).   
The type, and intensity of health-related late effects are associated with diagnosis, 
treatment type (chemotherapy, radiotherapy, or both), treatment dosage and duration, gender, age 
at diagnosis, and treatment location.  In a study using data from the National Childhood Cancer 
Survivors Study (CCSS) (Hudson, et al., 2003) found that demographic and treatment variables 
were associated with the adverse health-related outcomes of childhood cancer survivors. The six 
health domains measured were, general health, mental health, functional status, limitations of 
activity, pain as a result of the cancer or its treatment, and anxiety/fears as a result of the cancer 
or its treatment (Hudson, et al., 2003). Among survivors and their siblings, the prevalence of 
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adverse health outcomes in one of the six domains was associated with being female, having an 
annual household income of less than $20,000, and not completing high school (Hudson, et al., 
2003). Being female, was associated with reporting at least one adverse health outcome, in all 
domains except for pain (Hudson, et al., 2003). 
Type of cancer also played a role in the number of adverse health-related outcomes 
survivors reported post treatment. Survivors, who had central nervous system tumors, as well as 
bone tumors, reported more adverse health outcomes in functional status, activity status, and 
general health compared to survivors of leukemia (Hudson, et al., 2003). Type of treatment was 
also found to be associated with reporting more than one adverse health outcome; again 
survivors of central nervous system and bone tumors (often treated with surgery, radiation 
involving the head/brain, chest/mantle, or alkylating agent chemotherapy) were twice as likely as 
leukemia survivors to report adverse health outcomes (Hudson, et al., 2003).   
To aid in the detection of late effects, the Children’s Oncology Group (COG), has 
established a recommended late effects screening protocol for childhood cancer survivors. 
COG’s protocol is based on a patient’s cancer diagnosis, level of exposure to specific drugs, and 
the risk associated with developing specific late effects (Landier et al., 2004). Oncologists, 
nurses, and other clinicians treating childhood cancer patients and survivors developed these 
risk-based screening protocols based on evidence and practice experience. Many of the screening 
protocols can begin as soon as two years after the end of treatment but are separate from follow-
up care of the initial cancer diagnosis (Landier et al., 2004).  
While the majority of young adult survivors of childhood cancer are at risk for 
developing a late effect, most are not participating in recommended screening protocols to 
identify late effects (Schultz et al., 2010).  In a study conducted among 335 Swedish childhood 
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cancer survivors, researchers found that 60% of survivors of acute leukemia, lymphoma, or 
Wilms’ tumor, who were surveyed about their attendance at follow-up clinics or appointments, 
reported not having a follow-up appointment scheduled, even though 50% reported having 
negative symptoms related to their original cancer treatment (Arvidson, Söderhäll, Eksborg, 
Björk, & Kreuger, 2006). Nathan et al. (2009) found that among patients with a higher risk for 
developing cardiology problems or breast cancer because of the cancer treatment they received, 
only 28% susceptible to cardiology problems, and 41% susceptible to secondary breast cancer, 
participated in the recommended screening protocol for detection of these late effects. While 
healthcare providers and researchers are becoming more aware what late effects childhood 
cancer survivors are likely to develop, and which demographic characteristics of a childhood 
cancer survivor are associated with their likelihood to attend an appointment to screen for late 
effects, little is known about which behavioral factors influence childhood cancer survivors’ 
decisions to participate in late effects screening. 
Purpose of the Study 
The purpose of this study is to examine young adult survivors of childhood cancer 
participation in screening for late effects by: 1) identifying non-modifiable factors associated 
with young adult survivors of childhood cancer’s participation in screening for late effects; 2) 
identifying modifiable factors associated with young adult survivors of childhood cancer’s 
participation in screening for late effects; and 3) examining the relationship between identified 
factors and subsequent screening for late effects. The purpose of this study drives the three main 
research questions.  
Research Questions 
The following research questions were used to guide this study: 
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1. What factors are associated with young adult survivors of childhood cancers participation 
in screening for late effects? 
a. What are the non-modifiable factors associated with young adult survivors of 
childhood cancer’s participation in late effects screening? 
b. What are the modifiable factors associated with young adult survivors of 
childhood cancer’s participation in late effects screening? 
2. What is the relationship of modifiable factors to young adult survivors of childhood 
cancer’s participation in late effects screening? 
3. Can the Health Belief Mode be used to explain behavior of young adult survivors of 
childhood cancer as it relates to screening for late effects?  
 Theoretical Perspective 
The conceptual framework for this study incorporates two theoretical perspectives; the 
Health Belief Model (HBM) and grounded theory. The HBM is the primary theory underlying 
this proposed study; it links an individual’s values and expectancy to a health-related behavior.  
The major conceptual components assess an individual’s perception of the severity of an illness 
and the individual’s perception of their susceptibility to developing that illness. It assesses the 
individual’s perceived benefits of a specific health behavior and the perceived barriers the 
individual must overcome to participate in the behavior. These perceptions influence an 
individual’s behavioral intention, which is closely linked to whether or not an individual 
participates in a specific health behavior. The first phase of this study utilized the HBM.  
Using the HBM, if a survivor perceives themselves to be susceptible to developing late 
effects; perceives late effects to be severe enough; believes the benefits for screening for late 
effects outweigh the barriers to screening for late effects; and cues to action arise, then a survivor 
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may take action in screening for late effects. For this study, selected constructs were combined to 
form the independent variables. The HBM was central to assessing the relationship between 
these variables and a survivor’s intent to participate in screening for late effects. However, since 
only a few studies (Lupatsch, et. al., 2016; Michel, et. al., 2010) have utilized the HBM to assess 
childhood cancer survivors’ participation in late effects screening, a grounded theory approach 
was used to supplement known quantitative measures.  
During the second phase of the study a modified form of grounded theory was utilized to 
assess responses to supplemental qualitative interviews. In the late 1960s Glaser and Strauss 
developed grounded theory while undertaking the research study Awareness of Dying (1965).  
During the development of this theory, they emphasized the need to create theories that emerged 
from, and coincided with social research. They believed this method is “more successful than 
theories logically deduced from a priori assumptions” (Glaser & Strauss, 1967, p. 6). Glaser and 
Strauss stressed that the importance and function of ground theory is to discover an underlying 
theory that emerges from the systematic review of data (Kenny & Fourie, 2014). Grounded 
theory sets out a methodological procedure for developing a theory through the use of: 
theoretical sampling and coding, constant comparison, saturation, and memo writing, are used 
throughout the three stages of coding.  
Operational Definitions 
There are varying definitions for the terms that will be used throughout the remaining 
chapters. For the purpose of this study the following definitions of terms were used. 
Childhood cancer. Any cancer diagnosis as early as birth to as late as 18 years of age will be 
considered to have been childhood cancer. 
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Childhood cancer survivor. Any individual diagnosed with a childhood cancer that has 
completed treatment for their cancer diagnosis and is five years out from their last treatment is 
considered a childhood cancer survivor. 
Young adult. An individual who is between the ages of 18 and 29 years of age. 
Late effects. A physical or mental health condition associated with the treatment of a childhood 
cancer that has developed. 
Non-modifiable factors. Factors that cannot be changed. 
Gender. The set of characteristics that distinguishes man from woman. 
Education. The level of formal learning from elementary school through post-secondary 
education. 
Income. The total financial earnings of a family in the past year. 
Age. The numerical measure of time in years. Study participants between the 18 and 29 
years old.  
Age at diagnosis. The age when the participant was diagnosed with cancer. 
Diagnosis. The type of cancer the participant was initially identified as having during  
childhood. 
 
Modifiable factors. Factors that can be influenced or changed. 
Health Belief Model Constructs.  Six factors, known as constructs, are combined to create the 
Health Belief Model.   
 Perceived severity. A person’s beliefs about the impact a particular health condition 
could have on them if a particular behavior is not implemented (Janz, Champion, & Strecher, 
2002). When a survivor believes that late effects are serious enough to require early intervention. 
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Perceived susceptibility.  A person’s belief about how likely it is for them to develop a 
particular health condition (Janz et al., 2002). A survivor’s belief about how likely they are to 
develop a late effect. 
Perceived barriers. A person’s belief that certain obstructions are keeping them from  
completing the recommended health behaviors (Janz et al., 2002). A survivor’s belief that there 
are things keeping them from screening for late effects. 
Perceived benefits. A person’s belief that participating in a health behavior will reduce 
their health risk (Janz et al., 2002). A survivor’ belief in that screening for late effects will be 
effective in reducing the risks associated with late effects. 
Cues to action. Triggers that activate a person to take action (Janz et al., 2002). Specific 
thoughts or experience that will trigger a survivor to make or attend a late effects screening 
appointment.  
Self-efficacy. A person’s confidence in their ability to complete an action (Janz et al., 
2002). Survivors’ confidence is their ability to find a location for late effects screening, to 
schedule and attend a late effects screening appointment. 
Importance of the Study 
Current research has focused primarily on demographic and non-modifiable factors 
associated with a childhood cancer survivors’ participation in late effects screen. Factors such as 
race, knowledge about treatment, barriers to care, and time since treatment, which have been 
found to be associated with childhood cancer survivors’ non-participation in late effects 
screening. In a study that compared the late effects screening compliance of minorities to those 
of Caucasians, African Americans reported better preventative practices than all other races and 
African American females had the highest compliance rate for late effects screening (Castellino 
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et al., 2005). A survivor’s knowledge about their cancer treatment and their level of concern for 
their overall health has also been associated with their participation in late effects screening 
(Yeazel, 2004; Oeffinger, 2006) along with a lack of barriers to care (Park, et al., 2005). 
Although, the underlying purpose of the studies that identified these factors was not to identify 
modifiable or health belief factors that could be influenced through targeted program 
components. While the results of previous studies can be used to help predict which survivors are 
more likely to participate in late effects screening they do not provide insight on the beliefs or 
motivating factors that influence a survivor’s decision to participate in late effects screening.  
Chapter two will present a view of the available literature on the impact of childhood 
cancer treatment, screening for late effects as a form of health promotion, and the current 
literature that identifies non-modifiable factors associated with childhood cancer survivor’s 
participation in late effects screening. Additionally, late effects screening practices of other 
cancer populations, and how the HBM has been used to understand cancer-screening practices of 
other populations will be discussed.   




  Little is known about the modifiable factors influencing the late effects screening 
practices of young adult survivors of childhood cancer. Research has primarily focused on 
identifying the specific late effects associated with treatment protocols and assessing the rates of 
childhood cancer survivors’ participation in late effects and secondary malignancy screening 
behaviors. To date, studies have identified non-modifiable factors such as demographic and 
treatment factors associated with childhood cancer survivors’ participation in screening for late 
effects, but have not identified modifiable factors such as why childhood cancer survivors 
participate in late effects screening or what factors influence their decisions to screen for late 
effects. Chapter Two will describe the impacts of childhood cancer treatment, screening for late 
effects, late effects screening as a form of health promotion and prevention, the Health Belief 
Model as a theory to explain late effects screening practices.  
Impact of Childhood Cancer Treatment 
Childhood cancers affect patients in a variety of ways. Immediate side effects of 
treatment, such as nausea, hair loss, fatigue, loss of appetite, and other reactions to treatment are 
the most commonly known impacts. However, lesser known impacts include the financial costs 
of treatment, both direct and indirect and the long term side effects, known as late effects that 
develop months, years, and even decades after treatment for cancer is complete.  
The cost of treating childhood cancer has been measured in many different ways. Two 
distinct categories can be used to classify these types of measurements; direct and indirect costs. 
Direct costs, are the financial expenses incurred covering the cost of treatment and secondary 
conditions caused by chemotherapy or radiotherapy. Indirect costs are the financial deficits 
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survivors incur, such as loss of earning, or educational attainment compared to their non-cancer 
peers.  
Direct Costs 
Researchers have worked to quantify the financial cost of childhood cancer treatment. A 
study conducted in the early1980s in the United States, found that the average cost of childhood 
cancer treatment alone ranged from $8,000 to $53,000 (accounting for inflation this would be 
approximately $20,592 to $136,427 in 2019) depending on the type of cancer (Lansky, Black, & 
Cairns, 1983). Lansky et al. (1983) found that the majority of charges were due to inpatient care, 
that more than 50% of costs were incurred in the diagnostic and terminal stages of treatment and 
that insurance coverage does not cover the full amount needed for treatment. In the United 
Kingdom, researchers measured income loss of family members (primarily mothers who left 
fulltime positions to care for their child with cancer), as well as expenditures above that of the 
normal family expense. Eiser and Upton (2007) found that 34% of mothers who had fulltime 
employment quit their jobs to care for their child and that the household expenditures increased 
on average from £50–100 (approximately $69US –$138US) in the areas of travel, food, phone 
calls, gifts/ treats for the child and siblings, health food, clothing, childcare for siblings, home 
help, and accommodation. A cross sectional survey of parents who were caring for childhood 
cancer patients measured the extra costs incurred over the 30 days prior to the survey as a result 
of their child being in treatment. Dockerty, Skegg, and Williams (2003)  found that on average 
13% of the family’s income was spent on extra expenses such as increased electrical bills, 
parking and transportation costs, and an increase in medication and food expenditures.  
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Indirect Cost 
Indirect costs to survivors and their families can vary from unexpected extra expense to 
loss of educational and job attainment. A major financial concern for survivors of childhood 
cancer is their ability to obtain health insurance as adults. Prior to the Affordable Care Act 
childhood cancer survivors faced difficulty trying to obtain healthcare through employer plans 
and if they were able to obtain coverage, even with their preexisting condition, they were and are 
still, at risk for facing higher premiums (Park et al., 2005). Survivors of childhood cancer also 
reported less insurance coverage than their siblings; with 23% of survivors compared to 3% of 
siblings reporting difficulty in obtaining health insurance. Survivors of childhood cancer were 
also more likely to have public insurance than their siblings (Park et al., 2005).  
Survivors of childhood cancer are also at risk for lower educational and job related 
success than their siblings and peers. According to a study conducted using data from the CCSS, 
23% of survivors compared to 8% of their siblings used special education services in school, 
those survivors who did not utilize these services were at a greater risk for not completing high 
school or doing as well as their peers who did utilize these services (Mitby et al., 2003). Another 
study conducted using data from the Childhood Cancer Survivors Study established three 
occupational categories Managerial/Professional, Nonphysical Service/Blue Collar, and Physical 
Service/Blue Collar. Results from this study showed that compared to their siblings, childhood 
cancer survivors were less often in higher-skilled Managerial/Professional occupations than their 
siblings and within each of the categories survivors' personal income was lower than siblings 
even after adjusting for socio-demographic variables (Kirchhoff et al., 2010).  
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Late Effects 
Not only are the direct and indirect costs of treatment impactful to childhood cancer 
survivors, but childhood cancer survivors must also be aware of the physical and psychological 
cost they incur due to treatment in the form of late effects. These late effects can vary from 
delayed mortality to psychosocial issues.  
Delayed Mortality. Survivors of childhood cancer are at a higher risk of mortality than 
their peers and death is mainly due to their previous cancer, a secondary cancer, or a 
noncancerous cause (Möller, Garwicz, Barlow, Winther, Glattre, Olafsdottir, G., Hulinius, 2001). 
A retrospective study to assess the long-term risks associated with developing a secondary 
malignant neoplasm, a secondary cancerous tumor, was conducted using data from 1,285 5-year 
survivors of childhood cancer who were diagnosed between the ages of 20-24 in Great Britain. 
Researchers found that females and survivors of CNS tumors had a higher risk of death than 
male survivors or survivors of other cancers (Yang, Goddard, Spinelli, Gotay, & McBride, 
2012).  Survivors from Great Britain appeared to have a lower increase in mortality (six times 
that of non-survivors) than survivors in the United States who reported a 10.8 fold increase in 
mortality compared to their peers (Mertens, Yasui, Neglia, Potter, Nesbit, Ruccione, & Robison, 
(2001). In a retrospective study of 5-year childhood cancer survivors in the United States 
Mertens, et al. (2001) also found that females, those diagnosed with cancer before the age of 
five-years, and those with an initial diagnosis of leukemia or CNS tumor, had a statistically 
significant higher risk of delayed mortality. These researchers also found that increased risk of 
mortality was associated with cardiac, pulmonary, and other late effects (Mertens, et al., 2001). 
Nervous System Complication. The nervous system is the most common system/organ to 
be impacted by the treatment modalities of childhood cancer, occurring in 27% of survivors 
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(Skinner, 2012). The nervous system manages both the voluntary and involuntary functions of 
the body. Neurotoxicity is primarily found among survivors of CNS tumors as a consequence of 
cranial radiotherapy, or chemotherapies targeted at CNS tumors and can cause damage from 
delayed or lost motor functions to cognitive problems (Skinner, 2012).  
Hearing, Speech, and Vision Late Effects.  Over 12% of childhood cancer survivors 
report some form of sensory loss related to their initial cancer treatment (Skinner, 2012). Hearing 
loss, can lead to speech and educational delays, especially in younger survivors. A common late-
effect of retinoblastoma and orbital rhabdomyosarcoma, cancers that appear in or near the eye 
and require radiotherapy, are cataracts (82%) and decreased vision (70%) (McDowell, 2008).  
Endocrine System Complication. The endocrine system complications are the second 
most common late effects impacting 18% of childhood cancer survivors (Kopp, Gupta, Pelayo-
Katsanis, Wittman, & Katsanis, 2012). Hypothyroidism is the most common of the late effects of 
the endocrine system, in conjunction with it, survivors’ decreased ability to metabolize glucose 
and their developed insulin resistance, can lead to obesity (Kopp, et al., 2012).  
Reproductive late effects. Both male and female reproductive abilities are impacted by 
chemotherapy and radiotherapy. Chemotherapy and radiotherapy are known to cause delayed 
puberty or early onset puberty among children (Skinner, 2012). Damage to germ cells for both 
males and females are impacted by the lowest levels of radiation and lowest doses of 
chemotherapy; for males this can result in a decrease in the amount of testosterone and sperm 
produced and in females it can result in a decrease in the production of eggs (Skinner, 
2012).  Due to advancements in chemotherapy treatments, males who were at a greater risk of 
decreased sperm and testosterone production can usually recover to normal production levels 18 
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months after the completion of treatment (Viviani, Santoro, Ragni, Bonfante, Bestetti, & 
Bonadonna, 1985).  
Females who were treated with radiation in the thoracic region, as well as, those treated 
for Hodgkin’s Lymphoma were at a greater risk (12-20%) of developing breast cancer compared 
to the general public (Yang, et al. 2012).  Age at treatment is one of the most important risk 
factors for premature ovarian failure, the older the patient is at diagnosis the greater the risk for 
ovarian failure (Botha & Kruger, 2012). Girls who receive pelvic or abdominal irradiation or 
who receive total body irradiation, the removal of bad tissues from bone marrow, are at a greater 
risk for miscarriage, intra-uterine growth restriction and premature delivery (Green, Hall, & 
Zevon, 1989). 
 Psychosocial Late Effects. Measuring the psychosocial late effects of cancer treatment 
has been a challenge for researchers over the last two decades. Psychosocial late effects 
associated with health issues are often measured using quality of life (QOL) tools as it has 
become a way to measure individuals overall well-being, incorporating mental, physical, and 
social health. However, QOL tools for childhood cancer survivors have only recently been 
developed, and their success at measuring the physical and psychosocial well being of survivors 
is still up for debate. 
The use of harsh treatments have led to the development of late effects, at an increasing 
rate of 0.5% with a cumulative predicted rate of 25% within the next 50 years (Varan & Kebudi, 
2011). Among childhood cancer survivors, late effects have become the second leading cause of 
death (Mertens et al., 2001). While a majority of young adult survivors develop late effects, most 
are not participating in the screening activities necessary to identify and treat late effects (Schultz 
et al., 2010). 
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Screening for Late Effects 
Childhood cancer used to be treated as an illness that was either curable or terminal, but 
now as childhood cancer survivors live longer, they should be transitioning from cancer care into 
a new phase that is focused on identifying and treating the late effects of treatment known as 
survivorship care. Like many health issues, early detection of a late effect can impact the course 
of treatment (NCI, 2017).  
In 2003, the COG published their first set of risk-based recommendations for screening 
for late effects in Group Long-Term Follow-Up Guidelines for Survivors of Childhood, 
Adolescent, and Young Adult Cancers.  For each treatment modality, the strength of the drug or 
radiation, the quantity and frequency and total number of doses is considered in conjunction with 
the available evidence that connects the treatment with an adverse health outcome. A panel of 
experts then developed the recommendation for appropriate screenings and intervals for 
screening. The most recent version of the guidelines was published in 2013, is over 200 pages in 
length, and technical in language. To better equip survivors with knowledge about screening and 
late effects the COG developed shortened educational documents for survivors called Health 
Links. Yet very few childhood cancer survivors are participating in late effects screening. 
Childhood Cancer Survivors Participation in Late Effects Screening 
Non-Modifiable Factors Associated with Late Effects Screening 
Current research on childhood cancer survivors and their participation in late effects 
screening has focused on a number of factors that are non-modifiable. The non-modifiable 
factors that researchers have found to be associated with childhood cancer survivors participation 
in late effects screening include, gender, ethnicity, age, socio-economic status, and treatment 
modality. 
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Gender. A childhood cancer survivor’s gender is associated with participation in late 
effects screening behaviors. Male childhood cancer survivors have reported less participation in 
late effects screening compared to their female counterparts (Oeffinger, et. al., 2004). Uninsured 
males reported significantly fewer visits to physicians’ offices for cancer-related visits, than 
other males and women (Oeffinger, et. al., 2004). Female childhood cancer survivors who 
received hematopoietic cell transplants as part of their bone marrow transplant were more likely 
than their male counterparts to participate in screening for a late effect (Armenian, Sun, 
Francisco, Baker, Weisdorf, Forman, & Bhatia, 2011).  
Ethnicity. The role ethnicity plays in childhood cancer survivors participation in late 
effect screening has not been solidified. Oeffinger et. al. (2004) assessed the childhood cancer 
survivor’s attendance at cancer related physician appointments and found no significant 
difference in ethnicities or minorities attendance to a cancer-related physicians appointments. A 
study that used a subset of the data from the CCSS, aimed at assessing the healthcare use of 
minorities, found non-Hispanic blacks and Hispanics, utilized the same amount of cancer-related 
services as whites (Castellino, et. al, 2005). Hispanic male and female childhood cancer 
survivors reported more use of cancer-related physician services compared to white survivors 
and African American females reported higher compliance levels with late effects screening 
recommendations compared to whites, Hispanics, and their male counterparts (Castellino, et. al, 
2005).  
Age. Age is another demographic factor associated with participation in screening for late 
effects. Half of the childhood cancer survivors between the ages of 18 and 24 surveyed as part of 
the CCSS reported attending a cancer-related visit with a physician; as time from treatment and a 
survivor’s age increased, the proportion of childhood cancer survivors attending visits related to 
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their initial cancer diagnosis decreased (Oeffinger et. al., 2004). Among survivors of acute 
leukemia, lymphoma, and Wilm’s tumor, age was associated with participation in an 
appointment to screen for late effects, the younger a survivor was the more likely to attend an 
appointment (Arvidson, et. al., 2006). For childhood cancer survivors in Sweden, being younger 
was associated with attending a late effects follow up appointment (Michel, et. al., 2010).  
Socio-Economic Status. Lower socio economic levels are also associated with lack of 
participation in screening for late effects. Casillas, et. al. (2015) found that childhood cancer 
survivors earning less than $20,000 a year and having less than a high school degree, were 
independently associated with not attending an appointment for follow-up care related to initial 
cancer treatment. Childhood cancer survivors at risk for secondary cancers, were more likely to 
screen for breast cancer, colorectal cancer, and skin cancer if they had a college degree or higher 
(Nathan, et. al. 2010). Among childhood cancer survivors in Sweden, Michel, et. al. (2010)  
found being unemployed with a lower educational background was associated with attending a 
late effects follow up appointment, the opposite for American childhood cancer survivors. 
Diagnosis. Survivors of Hodgkin’s disease are at a higher risk for developing late effects 
than other childhood cancer survivors and while a greater percentage reported attending more 
appointments related to their initial cancer than their peers who were at a lower risk of a 
developing a late effect, 50% still reported not attending any type of physician appointment in 
the past two years (Oeffinger, et al. 2004). Nathan et. al. (2010) found that female survivors of 
childhood cancer who were at an increased risk of breast cancer reported lower levels of 
adherence to screening protocols (46%) than survivors at a lower risk of breast cancer (67%).  
Treatment modality. Childhood cancer survivors who received treatment that placed 
them at a higher risk for developing a late effect reported attending more physician visits than 
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their childhood cancer peers who were at a lower risk, however their attendance at physicians’ 
visits to screen for late effects decreased with age and time from treatment (Oeffinger, et. al, 
2004). Similarly, childhood cancer patients treated with high levels of anthracycline are at a 
greater risk for developing heart abnormalities (Lipshultz, et. al., 1995).  Of the childhood cancer 
survivors treated with levels of anthracyclines likely to cause cardiomyopathy only 51% reported 
attending a cancer related physician’s appointment in the past two years (Oeffinger, et. al. 2004).  
Survivors of childhood cancer who received a bone marrow transplant were also more likely than 
their fellow childhood cancer survivors to report attending a cancer-related physician’s visit to 
follow-up or screen for late effects (Bishop, et. al. 2010). 
Knowing which non-modifiable risk factors are associated with a childhood cancer 
survivor’s participation in late effects screening can only provide healthcare professionals 
working to transition survivors from treatment to screening with enough information to identify 
the survivors who may or may not screen for late effects. In order to understand and explain how 
childhood cancer survivors decide to participate in late effects screening and create health 
promotion programs for this population we need to know what modifiable factors influence a 
childhood cancer survivor’s decision to screen for late effect.   
Screening for Late Effects as a Form of Health Promotion and Prevention 
The main focus of health promotion and prevention programs is to get people healthy and 
keep them healthy. With the advancements in cancer treatment resulting in increased survivor 
rates, focus is shifting from curing patients to keeping them healthy with the use of health 
promotion and prevention strategies that will help them to detect late effects. Rowland (2008) 
lays out seven compelling reasons why health promotion is needed as part of cancer 
survivorship: (1) there are more cancer survivors now than ever before, (2) these survivors are 
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living longer, (3) survivors are at a greater risk for comorbidities complicated by previous cancer 
diagnosis, (4) treatments used to cure cancer can compromise a survivor’s health in many ways, 
(5) early intervention has the ability to reduce death and lessen the morbidity associated with 
cancer (6) survivors are requesting and are more interested in information on proper care post 
treatment (7) cancer as a life-threatening illness has such a profound effect on many people’s 
lives that it is teachable moment. Healthcare providers including doctors, nurses, and social 
workers are working to transition childhood cancer survivors from treatment to screening for late 
effects, with screening practices starting as early as two years post treatment. 
Over the years multiple theories have been developed to understand and explain how 
individuals make decisions associated with health behaviors, and what factors can be targeted to 
influence these decisions. The Health Belief Model is one of the most widely applied 
frameworks used to understand and influence modifiable health behaviors at the individual level 
(Janz, et. al., 2002). The development and modifications of the HBM will be briefly discussed in 
the next section, as well as, the application of the constructs of the HBM to childhood cancer 
survivors’.    
Health Belief Model 
The Health Belief Model was originally developed to explain the behavior of individuals 
who did not participate in free tuberculosis health screening in the 1950s by Hochbaum, 
Leventhal, Kegeles and Rosenstock (Janz, et. al., 2002). The theory’s five major constructs are: 
(1) perceived susceptibility, an individual’s assessment of their likelihood to develop the 
condition; (2) perceived severity, an individual’s belief in the seriousness of the condition and 
consequences; (3) perceived barrier, an individual’s assessment of the potential factors that 
discourage or impede the adoption of a specific behavior; (4) perceived benefits, an individual’s 
  24 
belief in the positive outcomes associated with adopting a particular behavior; and (5) cues to 
action, an individual’s readiness to take a health action or incentive to live a healthy life-style 
(Janz, et. al., 2002). The construct of self-efficacy, an individual’s belief in their ability to 
successfully take action towards the adoption of the behavior, was later added Rosenstock, 
Stretcher, and Becker in 1988 as a separate construct (Champion & Skinner,	2008).  
 
Figure 1. Health Belief Model Components Adapted from Champion and Skinner (2008). 
 
Since its initial inception the Health Belief Model has been used to understand numerous 
health screening behaviors, including screening for cancer in the general adult population as well 
in the adult cancer survivor population. In order to measure the constructs of the HBM and if and 
how they influence an individual’s behavioral intentions, a measurement tool was needed. 
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Champion developed the most widely implemented tool that uses the health belief model to 
assess screening behaviors of cancer survivor. 
Champion pioneered the development of a questionnaire, the Health Belief Model Scale, 
that related breast cancer screening with the constructs of the Health Belief Model and continued 
to develop a valid and reliable tool that measured the constructs of health motivation, 
susceptibility, benefits, and barriers (1984; 1999), and self-efficacy (Champion, Skinner, & 
Menon, 2005) as they relate to breast cancer screening behaviors.  
In a study conducted among women 35 years of age and older, using Champion’s Health 
Belief Model scale, perceived barriers, benefits, susceptibility, health motivation (a measure of 
cues to action) and confidence and control (measures of self-efficacy) were all found to be 
associated with a women’s participation in a self-breast exam (Champion, 1990). Similarly, 
among women screening for cervical cancer using Pap smear tests, 45.79% of the variance in 
screening behaviors could be explained by the five factors of the health belief model, benefits, 
barriers, motivation (cues to action), seriousness (severity), and susceptibility, over 15% of the 
variance was explained by benefits (Guvenc, Akyuz, & Açikel, 2011). Adding cost, fatalism, 
preference for female health professional, and the distance from the healthcare center were valid 
additions to the barriers construct (Guvenc, et. al., 2011). Among older Chinese adults screening 
for colorectal cancer, perceived susceptibility, severity, perceived benefits, and perceived 
barriers, and knowledge (a measure of self-efficacy) were associated with participation in 
screening for colorectal cancer (Leung, Wong, & Chan, 2014).  
While there are many differences between childhood cancers and adult cancers both in 
treatment and the life-stage at which the patient is treated for cancer, both types requires lifelong 
surveillance and screening to detect secondary cancers or other late effects. Wilkins and 
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Woodgate (2008) completed a comprehensive review of literature that compared the screening 
for secondary cancer practices of childhood cancer patients and adult survivors of cancer. 
Screening practices for testicular, colorectal, cervical, and breast cancer were compared between 
childhood and adult cancer survivors. Across the studies, the proportion of childhood cancer 
patients at risk for developing breast cancer who participated in a clinical breast examination was 
similar to adult survivors of breast cancer, yet fewer long-term survivors of childhood cancer 
reported mammograms compared to adult breast cancer survivors (Wilkins & Woodgate, 2008). 
While the late effects screening behaviors of childhood cancer survivors do not entirely mirror 
the screening behaviors of adult survivors of cancer they are similar and a starting point for 
understanding childhood cancer survivors’ late effects screening behaviors.  
Health Beliefs of Childhood Cancer Survivors 
The majority of studies that have identified HBM constructs associated with childhood 
cancer survivors’ participation in late effects screening have done so in a piecemeal fashion. 
Most studies have focused on one or two of the constructs of the HBM, rarely using the full 
model. 
Perceived Susceptibility. Using the data obtained from the CCSS, researchers analyzed 
the screening behaviors of childhood cancer survivors in relationship to a wide variety of 
demographical variables, such as age, race, and education level. They found that female 
survivors, who reported lower levels of concern for their health (perceived susceptibility) 
performed fewer mammograms than those who had higher levels of concern for their health 
(Yeazel et al., 2004). The researchers also found that female survivors who had a higher risk of 
developing breast cancer from treatment were more likely to complete breast self-exams and 
receive mammograms compared to their counterparts less at risk, as well as being more likely to 
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complete a self-exam than their siblings who had not gone through treatment (Yeazel et al., 
2004). Compared to females in this study, males reported a lower level of testicular screening 
behavior. Unlike females who received radiotherapy in a region of their body that could be 
associated with breast cancer, males in this study did not receive radiotherapy near their testicles. 
Thus females in this study were more likely to be susceptible to the cancer they were screening 
for as they received treatment that increased their risk of a late effect compared to their male 
counterparts that were not at an increased risk. However, this study retrospectively, selected 
questions from a large national survey in which the questions we not specifically designed to 
measure the constructs of the HBM.  
Using data from the same CCSS Nathan, et. al. (2010) assessed the screening behaviors 
of childhood cancer patients at average risk for developing cervical or breast cancer and the 
screening behaviors of childhood cancer survivors at increased risk for developing breast cancer, 
cervical, colorectal, and skin cancer. A majority of the survivors at average risk for breast or 
cervical cancer who reached the recommended screening age reported participating in a 
mammogram (76%) or Papanicolaou smear (81%) (Nathan, et. al., 2010). There was no 
association found between survivor’s level of participation in their screening behaviors and their 
level of concern for their future health, which could suggest that the survivors’ had a lack of 
perceived susceptibility to developing a second cancer (Nathan et al. 2010). Of the childhood 
cancer survivors from the same study who were at a greater risk for developing breast, cervical, 
colorectal, or skin cancer due to treatment modality, 46% reported receiving a mammogram, 
11.5% reported a colonoscopy, and only 26.6% reported having an examination of the skin 
cancer sites previously treated (Nathan, et. al, 2010).  Again, this study retrospectively selected 
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questions that were not specifically structured to measure the HBM constructs and only 
investigated one of the constructs.  
Using latent class analysis, Cox (2012) assessed responses from the Childhood Cancer 
Survivors Study and found that three distinct survivor profiles arose and could predict health 
behavioral intent to screen for late effects.  The worried (30%) class was comprised of survivors 
who reported the most health concerns, poor perceived health status, had greater cancer related 
fears and anxiety and were more motivated by extrinsic factors (Cox, 2012). The collaborative 
(55%) class of survivors had the most moderate concerns about their health while the self-
controlling (26%) class demonstrated the least concern for their health (Cox, 2012). The worried 
and collaborative childhood cancer survivors were more likely to have a cancer related 
appointment compared to the self-controlling survivors and a greater percentage of worried 
survivors (90%) had cancer-related appointments than collaborative (88%) (Cox, 2012). Worried 
survivors may perceive themselves to be at greater risk for developing a late effect 
(susceptibility) or perceive the severity of late effects require a cancer related appointment with a 
physician. 
Perceived Barriers. Insurance coverage has been studied among many populations as a 
potential barrier to accessing needed healthcare, including among childhood cancer survivors. 
Park, et al. (2005) used data from the baseline questionnaire from the 1994 Childhood Cancer 
Survivors’ Study and the supplemental follow-up questionnaire from 2000 to examine the 
incidence and predictors of childhood cancer survivors’ and their siblings’ access to insurance 
and the challenges they had in obtaining coverage. The authors found that in the six-year period 
between 1994 and 2000, both groups increased insurance coverage, patients increased from 83.9 
% to 88% and siblings from 88.3% to 91% (Park et al., 2005). While a difference in insurance 
  29 
coverage between siblings exists, the difference is not statistically different; suggesting coverage 
alone is not the primary barrier to follow-up care. This study did not consider whether or not 
insurers denied coverage of specific tests needed to screen for late effects. Oftentimes tests 
recommended to detect late effects, such as mammograms are covered for women of a certain 
age group and may not be covered for younger women without proper documentation. In a study 
conducted by Park et. al. (2005) the researchers did not address whether “insurance coverage” 
included denied claims for tests needed to screen for late effects. However, other studies have 
substantiated that survivors with and without insurance, are not seeking healthcare for concerns 
related to their primary cancer diagnosis. (Nathan, et al., 2009).   
Knowledge of treatment and late effects (measure of self-efficacy). Survivors’ lack of 
knowledge of their diagnosis and treatment protocols has also been considered to be associated 
with their lack of participation in screening for late effects. Kadan-Lottick et. al. (2002) 
conducted a telephone survey of 635 childhood cancer survivors and found that 72% of 
childhood cancer survivors could accurately report their diagnosis with precision, meaning they 
could specifically name their exact form of cancer, while 19% were able to accurately, but not 
precisely recall their diagnosis. This same study found that of patients treated with doxorubicin 
or daunorubicin, chemotherapies known to cause heart problems, less than a third of patient’s 
receiving those therapies could recall receiving them (33% and 8% respectively) (Kadan-Lottick 
et. al, 2002). Similarly, a Canadian study, conducted almost 30 years ago, aimed at identifying 
what factors were associated with a childhood cancer survivors’ acknowledgement of their 
cancer treatment, found that among 1,928 survivors of childhood cancer, 81% were able to 
identify that they were treated for cancer and 50% were able to recall the type of treatment 
received (Byrne, Lewis, Halamek, Connelly, & Mulvihill, 1989).  Survivors’ ability to recall that 
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they were treated for childhood cancer, and what their diagnosis was, can only provide current 
physicians with limited information about survivors’ risks for late effects and how to properly 
screen for them. Since many childhood cancer patients are treated at a young age, recalling exact 
drugs and dosages can be a struggle for young adult survivors of cancer and could indeed be 
associated with their lack of participation in screening for late effects. To date no studies have 
investigated perceived severity of developing a late effect or the perceived benefits of screening 
for late effects.  
All Constructs of the Health Belief Model. Only two studies to date have used the full 
Health Belief Model to assess childhood cancer survivors’ participation in screening for late 
effect. Sweden has conducted a nationwide long-term, large-scale, follow-up survey of childhood 
cancer survivors who registered with the Swiss Childhood Cancer Registry (Michel, et. al., 
2010).  Of the 1,487 survivors contacted 1,075 responded to the survey, with slightly more males 
participating than females (Michel, 2010).   Questions developed to measure the health belief 
constructs of perceived severity, perceived benefits, perceived barriers, and cues to action using a 
4 point Likert-scale, and susceptibility were assessed by requesting survivors mark on a 10cm 
scale how likely they might experience a late effect in the next ten years (Michel, et. al., 2010). 
All constructs of the Heath Belief Model were significantly associated with a survivors’ 
attendance at a late effects follow-up appointment specifically lower barriers to care, higher 
perceived susceptibility, severity, benefits and cues to action (Michel, et. al., 2010). When 
researchers accounted for medical characteristics only benefits, barriers and health value 
remained significant (Michel, et. al., 2010).  A follow-on study assessed adolescent survivors 
(age 16-21) attendance at late effects follow up appointments using the same questions from the 
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Swiss Childhood Cancer Survivors Study and found only perceived benefits and barriers to be 
associated with attendance at follow-up appointments (Lupatsch, et. al., 2016).  
 Currently, no studies have assessed American survivors of childhood cancer late effect 
screening behaviors utilizing the full Health Belief Model. The constructs of perceived barriers, 
perceived susceptibility, and cues to action have been explored as part of different studies (Park, 
et. al., 2005; Nathan, et. al., 2009; Yeazel et al., 2004; Nathan, et. al, 2010; Cox, 2012) but not as 
a whole.  
Figure 2. Health Belief Model 
 
The purpose of this study was to identify what modifiable factors are associated with 
young adult survivors of childhood cancer decision to participate in screening for late effects 
using the HBM as a starting point to understanding their health behaviors. With minimal 
research investigating health behavior theories to understand late effects screening practices of 
young adult survivors of childhood cancer additional qualitative data was collected to further 
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CHAPTER  III 
 RESEARCH METHODOLOGY 
Introduction 
 This chapter describes the methods used to study the factors that influence young adult 
survivors of childhood cancers participation in late effects screening behaviors. A mixed-
methods concurrent explanatory design with two phases: quantitative and qualitative data 
collection was used. Participants self-selected to participate in an online survey and chose to opt-
in to a one-on-one audiotaped interview. The sections of this chapter describe the research design 
and rationale for choosing the mixed-method design, study measures, data collection, and data 
analysis. 
Research Design  
Mixed-Methods 
A mixed-methods approach using a two-phase sequential exploratory design was 
implemented. Brynman (2006) sets out 16 typologies of reasons for using a mixed-method 
design, five of these were used to rationalize the mixed-methods for this study, and they include: 
offset, completeness, explanation, unexpected results, and sampling. Available research presents 
mixed results as to whether the Health Belief Model Scale explains young adult survivors of 
childhood cancer’s participation in late effects screenings and at the time of this study no other 
studies have identified modifiable or health belief factors influencing the late effects screening 
practices of young adult survivors of childhood cancer. Using a mixed methods design that 
collects quantitative data first followed by in-depth qualitative interviews helped to offset the 
strengths and weakness of each approach and provided a method for selecting the qualitative 
sample. With mixed results about the role HBM plays in young adult survivors of childhood 
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cancer’s participation in screening for late effects, a mixed-method design enabled collection of 
quantitative data to assess the role of the HBM and to collect additional data that provided a 
more complete explanation of the variables. Data collected during the qualitative portion of the 
study helped to both explain the results of the quantitative portion and understand the unexpected 
results.  
A mixed-method design allows qualitative and quantitative data to be used to supplement 
and further understand the research questions posed. Limited research has attempted to assess the 
modifiable factors that influence a childhood cancer survivor’s participation in late effects. The 
limited numbers of studies that have attempted to identify modifiable factors have primarily 
utilized portions of the HBM. However, these studies were not specifically designed to test the 
constructs of the model (Yeazel et al., 2004) as the measurement tool was not created or 
validated to measure the HBM and mixed results were reported (Michel, et. al., 2010; Lupatsch, 
et. al., 2016).   
Since the HBM was previously tested and some constructs were found to be associated 
with childhood cancer survivors’ participation in late effect screening the HBM was selected as 
the initial theory and as a starting point to identify a quantitative tool that would be able to 
specifically assess the HBM constructs as they related to participation in late effects screening.  
Champion’s Health Belief Model Scale [Appendix A] was developed to assess breast cancer 
patients’ participation in breast examination and has been adapted for use among different cancer 
populations (Guvenc, et. al., 2011; Leung, et. al., 2014; Oliver, et. al., 2011).   Permission was 
obtained from Champion [Appendix B] to modify her original scale for the purposes of this 
study. In the first phase of the study an adapted version of the HBM scale [Appendix C] was 
used among young adult survivors of childhood cancer. With little research conducted to assess 
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the HBM or any other behavioral health theory as it relates to young adult survivors of childhood 
cancer late effects screening behavior, a second qualitative phase with open-ended questions 
implemented. Results from the second phase was conducted to either support the results of the 
first phase or identify additional constructs that lead to a new model or the identification of a 
more appropriate theory. Figure 1. diagrams the two phases of the study. 
 




 The target population for this study was young adult survivors of childhood cancer 
between18-29 years old and five years post treatment for cancer. Young adults are at a unique 
time in their lives in which they are transitioning from the care and guidance of their parents to 
living and caring for their own needs. This time is filled with numerous developmental tasks 
including career identification and development, developing critical thinking and problem 
solving skills while making important life course decision, forming significant relationships like 
friendships and marriages (Beaty, 2002). These tasks while similar to those in other life stages 
are unique to the young adulthood. Defining the exact age range in which these developmental 
tasks occur has varied from as young as 16 to as old as 40. A shift in the age of those being 
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as old as 60 (Kinnear, & O’Toole, 2015). Most survivorship studies have defined young adult 
survivors up into the late 20s and early 30s (Fern & Whelan, 2013; Patenaude & Kupst, 2005; 
Bleyer, 2005; Bleyer et al., 2006; Rainusso, Wang, & Yustein, 2013). This time of transition can 
be challenging to a young adult who is also not managing the transition of responsibility for 
doctors’ appointments and the physical and emotional impacts treatment from cancer has had on 
these young adults. 
 Aside from the challenges and hurdles young adult survivors experience transitioning 
from youth to adulthood there are also gaps in services available for a young adult survivor. 
Most childhood cancer survivors receive treatment and follow-up care at a children’s hospital. 
During their young adult years they “age-out” or become too old to be treated at a children’s 
facility. They must navigate not only the identification of a primary care physician, but take 
charge of the necessary follow-up regimen to screen for potential late effects. Many primary care 
physicians are unaware of the necessary screening these patients need to monitor for the late 
effects associated with the treatment they received at an early age.  
Sample Size  
In order to obtain a power of .8 with significance of .05 the target sample size for the first 
phase of the study should have been179 participants. After two years of data collection and 
observing a decrease in the number of participants after each post in the different social media 
forums and groups the researcher decided to close the study and have it serve as a pilot test. A 
post-hoc power analysis was run comparing the 60% non-attendance rate at late effects 
appointments of childhood cancer survivors, to the sample rate of 26%, with a sample size of 92 
and an alpha of .05, the power calculation was 100%. 
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Eligibility and Exclusion Criteria 
        The target population for this sample was long-term young adult survivors of childhood 
cancer. For the purposes of this study a long-term young adult survivor of childhood cancer was 
defined as an individual diagnosed with childhood cancer between the ages of 0 - 18, a minimum 
of five years out since date of last treatment, and was between the ages of 18 and 29 years old. 
Pediatric cancer survivors who were five years off treatment for their initial diagnosis, but were 
actively receiving treatment for a secondary cancer were excluded from the study. Survivors who 
were not residents of the United States or using the United States healthcare system were 
excluded from the study as well.  
Setting 
        The quantitative portion of this study was conducted using an online survey and took 
place in the location of the participant’s choosing. The qualitative portion of this study was a 
series of in-depth questions that took place over the phone in the location of the participant’s 
choice.  
Recruitment Strategy 
A convenience sample was used to recruit participants in both phases of this study. 
Reaching long-term young adult cancer survivors to understand their screening behavior has 
proved challenging. Survivors in this age rang are also members of the millennial generation, of 
which, a majority (85%) report that they use at least one form of social media (Jiang, J., 2018).  
During Phase One of the study a targeted distribution of surveys using social media 
outlets was utilized. There are numerous online resources and communities available for young 
adult survivors of childhood cancer, from blog sites to Facebook support groups. Recruitment 
began by partnering with the Association of Pediatric Oncology Social Workers (APOSW). The 
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APOSW is the professional association for social workers and other allied health professionals 
who provide support and treatment to children and young adults with cancer and their family 
members. Members of the APOSW self-selected to share a link for the online survey on 
Facebook and survivorship pages, as well as group pages supported by APOSW members.  
After eight weeks, the response rate was 20 participants. An internet search was 
conducted and additional organizations who work with pediatric cancer patients as well as those 
with young adult survivor programs across the United States were contacted including, the 
Coalitions Against Childhood Cancer, Alex’s Lemonade Stand, St. Baldrick’s Foundation, I Had 
Cancer, Lacuna Loft and more (Appendix D). It was requested that these organizations share the 
survey link on their social media post as well as contact other organizations serving the same 
population.  
In addition to partnering with the APOSW and nonprofits serving the target population, 
an extensive search was completed to identify Facebook groups that were both open and closed. 
Terms used to identify appropriate groups included “young adult survivor of childhood cancer” 
“survivor of pediatric cancer” “long-term survivor of childhood cancer” “late effects of 
childhood cancer” as well as disease specific groups such as “Wilms Tumor” “Osteogenic 
Sarcoma” “Leukemia Survivor” “Acute Lymphoblastic Leukemia” “Acute Leukemia.” In total 
32 groups were identified with a combined total of 282,665 members. Frequency in which a post 
was made depended on the level of member participation. For groups with high participation 
(10+ posts a week) a post was made monthly, for groups in which there was low participation 
(less than 10 posts a month, and if the only post was made for this study) a post was made every 
other month. 
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This link remained available from August 2017 until June 2019. Once the participant 
clicked on the link, they were provided with an electronic consent form informing them of their 
rights as a participant and any potential risks. At the end of the online survey participants had the 
opportunity to enroll in the second portion of the study. They were provided a space to enter their 
phone number, email address, and select the best times and days of the week to be contacted. 
This information was not linked in any way to their responses and participants were made aware 
of this with a notice at the end of the questionnaire. 
During Phase Two of the study, participants who self-selected to be included in the 
interview portion were contacted, via e-mail up to three times to arrange a date and time to 
complete the interview. After three attempts, participants who did not respond were deemed as 
self-select out of the interview. Participants who responded were contacted at their preferred date 
and time. Participants confirmed their identity and a brief overview of the interview process and 
recording was provided. Participants were then informed they were being recorded. A script was 
read, [Appendix E] with information on the purposes of the study, estimated length, and request 
for verbal consent to continue. Only participants who gave verbal consent were interviewed with 
the open-ended questions. 
Phase One: Quantitative Data Collection 
In phase one of the study, young adult survivors of childhood cancer were recruited 
through online social media venues to complete an online adapted version of Champion’s Health 
Belief Model Scale, about their participation in late effects screening. Quantitative data was 
collected via Qualtrics®, an online data collection tool. The online survey remained open from 
August 2017 until June 2019. Once the survey was closed, responses were downloaded to a 
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MacBook Pro as a “csv” file; the data was cleaned and imported into IBM SPSS (Statistical 
Package for the Social Sciences). The data was stored in a password-protected electronic folder.  
Instrumentation 
       An adapted version of Champion’s Health Belief Model Constructs Instrument (1999) 
[Appendix C] was used to assess if the HBM can explain young adult survivors of childhood 
cancers screening for late effects. The instrument is comprised of six subscales. Each subscale 
uses a five-point Likert Scale that measures the modifiable/health belief variables. Perceived 
susceptibility is comprised of three items, perceived severity seven items; perceived benefits, 
five items; perceived barriers, ten items; cues to action seven items; and self-efficacy, ten items, 
as they relate to the a young adult survivor of childhood cancer’s participation in late effects 
screening behaviors. Strongly disagree is scored using a one and strongly agree is scored using a 
five.  
Validity and Reliability of the Instrument 
The original measurement tool was developed by Champion to measure the perceptions 
and beliefs of women regarding breast cancer screening (Champion, 1999). The Health Belief 
Construct Scale was tested and re-tested to assess validity and reliability. The original scales for 
perceived severity, perceived susceptibility, and perceived barriers were originally found to be 
internally reliable and consistent. Adjustments to the measures of perceived barriers and cues to 
action were made and re-tested. The finalized tool was tested and found to be valid and reliable 
(Champion, 1999). 
Since the development of the tool, it has been translated and tested for validity and 
reliability in numerous languages including, but not limited to Arabic, Greek, Korean, 
Lithuanian, Malay, Spanish, and Turkish (α =0.61-0.94), (Abolfotouh, BaniMustafa, Mahfouz, 
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Al-Assiri, Al-Juhani, & Alaskar, 2015; Anagnostopoulos, Dimitrakaki, Niakas, & Tountas, 2013; 
Lee, Kim, & Song, 2002; Zelviene, & Bogusevicius, 2007; Parsa, et. al., 2008; Medina-
Shepherd, & Kleier, 2010; Yilmaz, & Sayin, 2014). The tool has also been adapted and tested 
and found reliable and valid for Pap smear and cervical cancer screening (α= 0.62-0.86), 
colorectal cancer screening (α= 0.95), and prostate cancer screening (Guvenc, et. al., 2011; 
Leung, et. al., 2014; Oliver, et. al., 2011).  Literature has supported the construct validity of the 
instrument.  
At the end of the online survey young adult childhood cancer survivors had the 
opportunity to opt-into the second phase of the study by providing their phone number and e-
mail address so that a brief interview comprised of open-ended questions could be conducted.  
Scoring of the Instrument 
Each construct is individually measured using a summation of the scores from the items 
measuring that construct (Champion, 1999; Champion, Skinner, & Menon, 2005). Perception of 
behavior is a survivor’s belief about the importance of screening for late effects. This variable is 
measured by subtracting the final score of the eight-item scale that measures survivors’ 
perceived barriers to screening for late effects from the final score of the five-item scale that 
measures survivors’ perceived benefits of screening for late effects. Perceived Threat is a 
survivor’s perception that late effects pose a threat to their health. Perceived Threat is measured 
by combining the summative results of the 12-item sub-scale that measures survivors’ perceived 
severity of late effects with the summative results of the five –item sub-scales that measures 
survivors’ perceived susceptibility of late effects. Cues to Action are the concerns survivors have 
to live a healthy lifestyle. Cues to Action are measured using an eight-item sub-scale that 
assesses a survivor’s desire to live a healthy lifestyle. Self-efficacy, a survivor’s belief that they 
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have the ability to schedule appointments specifically for late effects screening, is measured 
using a 12-item scale that measures survivors’ beliefs in their ability to recognize potential late 
effects and who they should call to schedule an appointment, for late effects screening. The 
subscales are summed individually, and the higher the score the higher the survivors perception 
or feeling about the construct (Guvenc, Akyuz, & Açikel, 2011; Louis, 2016). 
Quantitative Data Analysis 
Data was downloaded as a “csv” file and imported into Excel. SPSS was used to analyze 
the result from the adapted version of Champions Health Belief Model scale. A cross tabulation 
was computed and results were used to describe the sample characteristics using frequencies, 
percentages, measures of central tendency, and variability.  
Binomial logistic regression was initially proposed to answer research questions one and 
two and the corresponding sub questions. Logistic regression requires a complete data set 
without any missing fields to account for this the electronic survey did not allow for any 
unanswered question. Before running any of the logistic regression tests to assess research 
questions one and two, a cross tabulation table was assessed to ensure that data was collected 
from all combination of independent variables. If cells had less than five variables and the levels 
within the variables could be reduced, they were re-categorized post-hoc (Wong, 2012).  
When the initial model was run, extremely large standard errors were reported, in the tens 
and hundred of thousands, which is indicative of separation occurring. The two primary causes 
of separation are too many variable in the model including the number of levels within each 
variable, and a small sample size. Recommendations for addressing too many variables are to 
reduce the number of levels within the variables, as well as reduce the number of categorical 
variables, which was done.  
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Firth Regression, a penalized regression method, was implemented to adjust for the high 
number of variables and small sample size. Unlike binomial logistic regression, the Firth 
Regression method in SPSS does not allow for hierarchical regression (block) or stepwise entry 
methods. Hierarchical entry method allows researchers to enter variables into the model based on 
past research with known predictor variables being entered in to the model first. In the stepwise 
method predictor variables are added one at a time to the model (Field, 2009).  
 
To answer research question one all the non-modifiable variables assessed in the survey were 
forced entered using the firth regression method (Model One). A second firth regression (Model 
Two) was implemented which included the non-modifiable variables identified through previous 
research as being associated with survivor’s participation in late-effects screening practices. 
Table 1. Statistical Analysis Plan 
   
Research Questions Measures Statistical Test 
1. What factors are associated with young 
adult survivors of childhood cancers 




Cross tabulation  
(Chi-Square, Pearson's Product 
Moment Correlation, Fischer's 
Exact Test) 
a. What are the non-modifiable factors 
associated with young adult survivors of 





Cross tabulation  
(Chi-Square, Pearson's Product 
Moment Correlation, Fischer's 
Exact Test) 
b. What are the modifiable factors associated 
with young adult survivors of childhood 





Firth Logistic Regression 
(Penalized Binomial Logistic 
Regression) 
2. What is the relationship of modifiable 
factors to young adult survivors of childhood 





Firth Logistic Regression 
(Penalized Binomial Logistic 
Regression) 
3. Can the health belief model be used to 
explain behavior of young adult survivors of 
childhood cancer as it relates to screening for 
late effects?  
Modified Health 
Belief Model 
Scale & Phone 
Interviews  
Firth Logistic Regression 
(Penalized Binomial Logistic 
Regression) 
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These models identified the non-modifiable variables associated with a survivor’s reported 
likelihood of participating in a late effects screening appointing in the next year. The variables 
identified in the first two models to be associated with a survivor’s likelihood in participating in 
a late effects screening appointment in the next year were then included in the next round of 
regression analyses.   
 To answer research questions 1b. What modifiable factors were associated with young adult 
survivors of childhood cancer’s participation in late effects screening and research question 2-
“What is the relationship of health belief factors to young adult survivors of childhood cancer’s 
participation in late effects screening?” firth regression analyses were used. The modifiable 
variables of the HBM, were force entered using the firth regression method to assess which 
modifiable factors were associated with the intent to screen for late effects (Model Three). In 
addition, the HBM modifiable constructs we force entered using the firth regression method in 
Model Four.  
1. What factors are associated with young adult survivors of childhood cancers participation 
in screening for late effects? 
a. What are the non-modifiable factors associated with young adult survivors of 
childhood cancer’s participation in late effects screening? 
b. What are the modifiable factors associated with young adult survivors of 
childhood cancer’s participation in late effects screening? 
2. What is the relationship of modifiable factors to young adult survivors of childhood 
cancer’s participation in late effects screening? 
The non-modifiable factors in research question 1a. included demographic variables; age 
at survey, gender, race, marital status, income, education level, employment status, insurance 
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status, and residential area type. The treatment related non-modifiable variables were; age at 
diagnosis, time since last treatment, time since last late effects screening appointment, and 
diagnosis. The non-modifiable factors were measured at the interval, ordinal, and categorical 
levels. The dependent variable, how likely a survivor was to attend a late effects screening in the 
next year, was measured at the ordinal level.  
The modifiable variables, constructs of the health belief model, perceived susceptibility, 
perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy were 
measured at the ordinal level using a five-point Likert Scale ranging from one being extremely 
disagree to five being extremely agree. The outcome variable was also measured at the ordinal 
level using a five-point Likert Scale and was reduced to a binomial variable, yes or no. 
Extremely Likely and Likely were re-categorized as yes, Extremely Unlikely and Unlikely were 
categorized as No, and participants who selected “Neither Likely or Unlikely were re-
categorized based on their response to the last time they attended a late effects screening 
appointment. If a participant had attended an appointment in the last two years their response 
was categorized as ‘yes’, and if they responded they hadn’t attended one in over two years, 
including never, they were re-categorized to ‘no.’ The Health Belief Model Constructs perceived 
susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-
efficacy were entered in to a logistic regression analysis using a force entry method. No previous 
studies provide guidance on which independent variables are more influential on survivors of 
childhood cancer’s late effects screening behavior.  
Phase Two: Qualitative Data Collection and Handling 
For the second phase of the study, participants who provided their phone numbers were 
sent an initial introductory e-mail requesting specific times and days that would work best for the 
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participant. After receipt of dates and times the researcher returned each e-mail with a specific 
time and requested confirmation of the agreed upon interview time and date. Phone calls were 
made using an iPhone 6s and recorded with TapeACall App. The researcher called each 
participant, introduced herself, and informed the participant that she would begin recording the 
phone call. A review of the purpose of the study, potential benefits and risks were explained to 
the participant and verbal consent was acquired. Phone interviews recorded using TapeACall 
App were saved as MP3 files and immediately sent via AirDrop from the connected iPhone to 
the researcher’s MacBook Pro. Recorded interviews were saved with a coded name “Interview 1 
mm.dd.yyyy” and so on, saved to a password-protected file on the researcher’s MacBookPro. 
Once the file was successfully transferred and saved the recorded interview was deleted from the 
phone. The MP3 files were uploaded to the MAXQDA. The researcher transcribed interviews in 
MAXQDA.     
The questions for the telephone interview were used to provide context and meaning to 
the responses survivors provided in the online survey. Data from the online quantitative survey 
was kept separate from the respondents’ contact information to ensure that their responses to the 
online survey remained anonymous to the researcher.  
The first six questions of the interview were used to obtain demographic information. The 
following five questions related to treatment information. Both the demographic and treatment 
data collected during the phone interviews was collected in order to determine if the phone 
interview sample was similar to the sample of childhood cancer survivors who responded to the 
online survey. The five open-ended questions were developed to illicit responses that either, 
supported constructs of the HBM, provide insight or clarification to responses, or identify 
variables not measured by the quantitative survey. Question one, “When thinking about making 
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an appointment for late effects, what comes to mind?” was intended to illicit responses related to 
factors survivors’ associate with late effect screening appointments. Question two, “How do you 
think late effects could or do impact your life?” was intended to illicit responses related to the 
constructs of severity, susceptibility, or identify additional factors survivors associate with late 
effect screening. Question Three,   “Have you attended an appointment to screen for late effects 
in the past year?” assessed participants’ participation in late effects screening appointments. 
Question 4 “What influences your decision on whether or not to make an appointment to screen 
for late effects?” was intended to understand what internal and external factors motivated a 
participant to schedule a late effects screening appointment. Question 5 – “What things influence 
your decision to attend an appointment to screen for late effects” was intended to elicit responses 
that distinguished the difference between what motivates a survivor to schedule the appointment 
and what motivates them to follow through on attending the appointment they scheduled versus 
canceling or not attending at all. At the end of these questions participants were invited to share 
any other thoughts or comments they had about late effects and screening for them.  
The audio-recorded responses to the interview questions were uploaded into MAXQDA 
qualitative data analysis software.  Interviews were transcribed in MAXQDA. Demographic data 
was tagged for each respondent and a data table was created and used to assess descriptive 
statistics of the participants in Phase Two of the study.  
Qualitative Data Analysis 
A grounded theory method of data analysis was used to assess the content of the recorded 
phone interviews. The final product of a study using ground theory is a comprehensive theory 
derived from qualitative data. Since limited research has been conducted to assess the modifiable 
variables that influence a young adult survivor of childhood cancer’s participation in late effects 
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screening and these studies have reported conflicting results on whether or not the HBM can 
explain survivors’ behavior, grounded theory data analysis of the open-ended interview was 
selected. Results from the analysis of the qualitative data helped answer research questions one 
through three. The themes that developed 
will either further support the constructs of 
the HBM, help to explain young adult 
survivors of childhood cancer’s participation 
in late effects screening or identify other 
variables that influence a survivor’s intent to 
participate in screening. 
Coding. Coding is a process in which 
researchers identify themes found within 
qualitative data sets. Through coding data 
that was collected during the qualitative 
interviews were categorized based on the 
different subjects represented. Constant 
comparison and memoing were used during 
all three stages of coding. As categories 
developed and gain depth constant 
comparison was used among the responses 
simultaneously and concurrently to analyze 
the collected data (Jones and Alony, 2011). 





























Figure 3. Grounded theory process adapted from Jones 
& Alony (2011). Coding and Memoing 
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become more apparent, memoing is used to help develop the categories and their relationships. 
Memoing eventually lead to hypotheses and the formation of the theory. There are three levels of 
coding that are consecutive and sequential with the product of each stage of coding leading to the 
next. Figure 3 provides a visual illustration of the three coding stages of grounded theory. During 
the first round of review, open coding occurred to identify broad themes that arose. 
Open coding. The transcribed interviews were reviewed and 40 initial codes arose. 
Selective coding.  During the second stage of coding, core categories began to form. A 
core category explains most of the variation, which represents the participants’ major concern. 
These identified core categories should relate in a meaningful way to the other categories 
(Glaser, 1978). This stage of coding enables the researcher to clarify and code data to identify 
more relevant concepts. Selective coding continued until the categories become saturated, and no 
other codes emerged.  
Theoretical coding. The last of the three stages of coding occurs once the categories 
become saturated. Saturation occurs when no new data is found after extensive data collection 
seeking new categories of evidence. Examination of the categories helps to provide the 
researchers with information to develop the relationships between the identified categories as 
well as the literature (Glaser, 1992; 2005; Glaser & Kaplan 1996). Theoretical coding links 
themes into a meaning causal relationship.  
Ethical Considerations 
  The primary ethical considerations for all research studies are to ensure participants are 
well informed about the research they are being asked to participate in, are informed about the 
risks to they face as participants in the study, understand the benefits of their participation in the 
study, and to feel free to make an informed decision as to whether or not they wish to participate. 
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These ethical considerations were addressed through informed consent in both the online survey 
and the telephone interview. Potential stress or unease may have been experienced while 
completing the online survey. As part of the consent form, contact information for members of 
the research team we made available so that researchers could refer participants to resources 
should they experience distress from recalling aspect of their cancer treatment. The interviewer 
paid close attention to verbal cues during the interview and provided the phone and website to 
the American Childhood Cancer Organization (ACCO). The ACCO is able to refer survivors to 
in-person services in their area, provide services over the phone, as well as electronic services 
via online chat rooms and message boards. 
Maintaining confidentiality, especially when highlighting specific quotations for the final 
report was also an ethical concern of this study. Extreme care was taken when selecting 
quotations to ensure that even other participants could not identify the source. Emotional harm 
was a potential concern, as there may have been numerous negative emotions associated with 
survivors’ treatment experience. This harm was weighed against the potential benefit of the 
results of the study, and was addressed through proper consent. 
This study was submitted to and approved by the Old Dominion University Institutional 
Review Board, as was the amendment to include an incentive. 




The purposed of this study was to examine the late effects screening behaviors of young 
adult survivors of childhood cancer between the ages of 18-29 years old and identify the 
variables that influence their behaviors. The Health Belief Model (HBM) was the primary 
framework of the quantitative survey analysis and a grounded theory approach was taken to 
identify themes within a series of open-ended questions related to late effects and screening 
practices. The qualitative data was analyzed using SPPS and MAXQDA was used for 
transcription and coding of the open-ended questions and qualitative analysis.  
Phase One: Quantitative Data Analysis 
Data Handling 
The survey was distributed online to a minimum of 32 different social media outlets (14 
Facebook Pages, 15 Private Facebook Groups, 9 Twitter) with a combined exposure to 282, 655 
individuals. However, there was no way to de-duplicate the number of potential participants by 
page or group, nor was there a way to only distribute to eligible participants, by age or 
nationality. To address these limitations, responses that were from participants outside the 
demographic parameters were excluded.   
Survey data was collected using Qualtrics provided through Old Dominion. The survey 
remained open for two years. Responses were checked multiple times a week to schedule phone 
interviews. After the first year, 38 eligible responses were collected. An addendum to the study 
was made to incorporate a raffle incentive. After another year the remaining surveys were 
collected. If a survey was attempted but not completed within 14 days, the survey was recorded 
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as incomplete.  The survey was closed after two years and responses were downloaded as a “csv” 
file and stored in a password-protected electronic folder. 
All Likert-Scale responses were coded one through five, one being extremely unlikely 
and five being extremely likely.  
Description of the Sample 
 A total of 164 individuals clicked on the anonymous link to the questionnaire. 
Figure 3. diagrams the enrollment of participants for both phases of the study. Of those who 
initiated the survey, 102 individuals completed the survey to the thank you page, two participants 
completed all questions but exited before the thank you page and 62 individuals abandoned the 
survey at various points. Of the 102 surveys completed, four were excluded because they were 
over 18 at the time they were initially diagnosed with cancer, four excluded because they self-
disclosed they were not a United States resident, one was excluded because a parent completed 
the survey for the survivor, and one was excluded as the participant was still actively in 
treatment. The final sample of Phase One consisted of 92 participants ranging from 18 years to 
29 years (M=23.9,SD=3.4).  
The majority of participants were female (n=74, 80.4%), with less than one-third being 
male (n=18, 19.6%).  Participants were predominately White (n=78, 84.8%). Hispanic/Latino(s) 
(n=9, 9.8%), African American (n=3, 3.3%), and Multiracial (n=2, 2.2%) participants comprised 
the remaining 15.2% of respondents. A little more than one-third of participants (n=34, 37.4%) 
earned a Bachelor degree or higher.    
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Figure 4. Recruitment and Enrollment of Study Participants 
 
Other demographic data explored were marital status, household income, and residential 
location. A large majority of young adult survivors (n= 70, 76.1%) were single. In addition, 
64.1% (n=59) of participants lived in urban and suburban residential locations. 
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Table 2. Characteristics of Childhood Cancer Survivors Quantitative Participants 
 
  Total Attend Appointment (n=68) 
Not Attend Appointment 
(N=92) (n =24) 
Characteristic Frequency % Frequency % Frequency % p-value 
Age (Mean, SD)        Age at Diagnosis 8.6 5.2 7.9 5.1 9.3 5.4 .278 
Age at Survey 23.9 3.4 23.2 3.4 25.9 2.8 .001** 
Years Since 
Treatment 13.7 5.8 13.4 5.9 24.3 5.7 .513 
Insurance Age       .029* 
<26 58 63 47 81 11 19  
≥ 26 34 37 20 58.8 14 
41.
2  
Sex        Female 66 71.7 51 82.3 15 75 .522 
Male 16 28.3 11 17.7 5 25 
 Race        White 78 84.8 56 83.6 22 88 .751 
Non-White 14 15.2 11 16.4 3 12 
 Marital Status        Married 21 22.8 13 17.7 8 30 .503 
Single 70 76.1 50 80.6 14 70  Prefer not to 
answer 1 1.1 1 1.6 0 0  
Education Level        Bachelor's or 
higher 34 37 22 32.8 12 48 .18 
Non-graduate 58 63 45 67.2 13 22.4  
Employment         Employed 54 58.7 38 56.7 16 64 .636 
Unemployed 38 41.3 29 43.3 9 36  Income            $0-19,999 19 20.7 18 26.9 1 4 .083 
 $20,000 to  
$49,999 
27 29.3 18 26.9 9 36  
$50,000 to 
$74,999 14 15.2 10 14.9 4 16  
$75,000 to 
$99,999 9 9.8 4 6 5 20  
 
$100,000 or more 10 10.9 7 10.4 3 12  Prefer not to 
answer 13 14.1 10 14.9 3 12  
Insurance Source        




Table 2. Characteristics of Childhood Cancer Survivors Quantitative Participants (continued) 
 




Not Attend Appointment 
(n=24) 
Characteristic Frequency % Frequency % Frequency % p-value 
Employer 22 23.9 12 17.9 10 40 .064 
Spouse or Parent 47 51.1 37 55.2 10 40  Purchased 7 7.6 4 6 3 12  Medicare or 
Medicaid 16 17.4 14 20.9 2 8  
Diagnosis        Leukemia 29 31.5 20 29.9 9 36 .381 
Lymphoma 13 14.1 8 11.9 5 20  Bone of Soft 
Tissue 13 14.1 10 14.9 3 12  
Central Nervous 
System 8 8.7 7 11.3 1 5  
Neuroblastoma 9 9.8 3 4.8 2 10  Other 20 21.7 15 24.2 2 10  Time Since Last Late  
Effects Appointment    .02* 
Never Attended 6 7.1 3 4.8 3 15  Less than a year 51 60.7 45 72.6 5 25  More than a year 15 17.9 10 16.1 5 25 
 More than two 
years 7 8.3 3 4.8 4 20 
 More than five   
years  5 6 1 15 3 1.6 
 Notes: SD, Standard Deviation. Comparisons used Chi-square, Fischer’s Exact appropriate to the level of 
measurement. p<.05* , p <.01** 
 
Specific non-modifiable factors related to participants’ diagnosis and treatment history 
were also analyzed. The majority of diagnoses were comprised of Leukemia; the most frequent 
(n=29, 31.5%) followed by bone or soft tissue cancers (n=13,14.1%) and lymphoma, (n=13, 
14.1%). The ‘Other’ category was composed of seven diagnoses; Kidney tumor (n=5), 
Retinoblastoma (n=3), Germ Cell (n=2), Heptoblastoma (n=2), Ovarian (n=2), Ewing’s Sarcoma 
(n=1), Pleuropulmonary Blastoma (n=1), and T-cell ALL and Non-Hodgkin’s Lymphoma (n=1). 
The majority of survivors did not experience a secondary cancer or relapses (n=66, 83.5%). The 
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majority of patients were diagnosed under the age of 10 years old (n=47, 60.2%).  The range of 
years since treatment spanned 21 years from five years since treatment to 26 years since 
treatment and the majority of participants (n=47, 60.3%) had attended an appointment to screen 
for late effects within the last year.  Compared to survivors who were not likely to attend a late 
effects screening appointment in the next year, survivors who were likely to attend an 
appointment were younger at the time of the survey (M=23.2, p=0.001) less than 26 (p=.029). 
Time since last late effects appointment was significantly different between survivors who were 
likely to attend a late effects  
Description of Score of the Health Belief Model Scale 
 The Health Belief Model Scale has six subscales that correspond with the six constructs 
of the Health Belief Model. Table 2. details the subscales, the minimum and maximum total 
score for each subscale, the observed range of the subscale scores and the measures of central 
tendency for each subscales. With the exception of Perceived Benefits, none of the six subscales 
covered the full span of the score range; all five other subscales were above the minimum score.  
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Identifying Non-modifiable and Modifiable Variables  
 Binomial Logistic Regression was proposed to assess research questions one and two. 
However, extremely large standard errors occurred which is indicative of separation. A table of 
the results of this test can be found in Appendix F. To address separation, the number of levels 
within each variable was reduced. Firth Regression, a statistical method for penalizing the 
regression was also used to address issues of small sample size, but requires that all variables be 
entered at once. In order to address over fitting the model with too many variables, three models 
were tested. Model 1. Included all of the measured non-modifiable variables. Time since last late 
effects appointment was found to be a significant contributing factor to the model and was 
included in Model 2. 
  
Table 3. Description of Health Belief Model Scale Scores 
 







Perceived Susceptibility 3 3-15 4-15 11.93(2.78) 
Perceived Severity 7 7-35 12-35 23.01(4.86) 
Perceived Benefits 5 5-25 5-25 18.67(3.92) 
Perceived Barriers 10 10-50 11-50 24.15(8.28) 
Self Efficacy 7 7-35 16-50 41.13(6.70) 
Cues To Action 10 10-50 16-35 27.88(3.79) 
 
  
  Perceived Threat  
(Perceived Susceptibility + 
Perceived Severity) 
10 10-50 20-50 34.95(6.25) 
Perception of Behavior 
(Perceived Benefits –
Perceived Barriers) 
15 -45-15 -30-14 -5.48(9.09) 
Notes: M, Mean; SD, Standard Deviation. 
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Table 4. Odds Ratio for Model One - All Non-Modifiable Variables 
 
 
  B (SE) OR  (95%CI) 
Intercept -4.58(6.28) 97.42 (-25.20	–	7.85)	
Demographic Variables   
	Age -0.17(0.20) 1.19 (-0.74	–	0.29)	
Gender   
	Male   
	Female -0.38(1.11) 1.46 (-3.09	–	1.92)	
Race   
	Non-White   
	White -1.05(1.15) 2.85 (-4.95	–	1.06)	
College Graduate   
	Not a college graduate   
	Bachelor’s degree of higher -1.08(0.91) 2.94 (-3.38	–	0.89)	
Marital Status   
	Prefer not to answer   
	Married 0.13(3.38) 0.88 (-7.33	–	6.96)	
Single 0.45(3.07) 0.64 (-5.67	–	6.16)	
Employment   
	Unemployed   
	Employed 0.55(1.12) 0.57 (-1.64-3.83)	
Income   
	Prefer not to answer   
	Under $20,000 1.33(1.95) 0.26 (-3.75-12.43)	
$20,000 to$49,999 -1.06(1.37) 2.89 (-4.36	–	2.95)	
$50,000 to $74,999 -0.66(1.41) 1.94 	(-4.84	–	2.66)	
$75,000 to $99,999 -1.72(1.43) 5.56 (-5.69	–	1.36)	
$100,000 or more -1.38(1.55) 3.97 (-5.62-1.65)	
Insurance Source   
	Employer Provided   
	Spouse or parent 0.03(1.06) 0.97 (-2.30	–	2.09)	
Purchased Policy 0.24(1.89) 0.79 (-4.16	–	4.48)	
Medicare or Medicaid 0.48(1.66) 0.62 (-3.21	–	5.16)	
Residential Locality   
	Other   
	Rural 6.82(3.65) 0 (-0.28	–	22.80)	
Small town 5.32(3.42) 0 (-1.41	–	20.41)	
Suburban 5.84(3.41) 0 (-0.77	–	19.51)	
Urban 6.78(3.41) 0 (3.41	–	0.14)	
Treatment Variables    
	Age at Diagnosis 0.06(0.14) 0.95 (-0.35	–	0.04)	
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Years Since Treatment 0.09(0.13) 0.91 (-0.29	–	0.45)	
Table 4. Odds Ratio for Model One - All Non-Modifiable Variables (continued) 
	
 B (SE) OR  (95%CI)	
Diagnosis   
	Other 1.07(1.18) 0.34 (-1.35	–	4.17)	
Leukemia -0.26(1.32) 1.3 (-3.27	–	2.77)	
Lymphoma 1.72(1.56) 0.18 (-1.23	–	7.29)	
Bone or Soft Tissue 0.33(1.55) 0.72 (-2.97	–	3.81)	
Central Nervous System 0.32(1.68) 0.73 (-3.35	–	4.15)	
Time Since Last Late Effects Appointment   
	Never Attend   
	Less than 6 months ago 3.30(1.570 0.04 (0.56	–	9.54)	
More than 6 months but less than a year 5.64(1.87) 0 (2.08	–	15.93)	
More than one year 1.93(1.52) 0.15 (-0.85	–	7.68)	
More than two years 2.04(1.79) 0.13 (-1.20 – 8.12) 
B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*, p<.001** 
 
In model one, time since last late effects appointment was a significant predictor of a 
childhood cancer survivors’ likelihood to participate in a late effects screening appointment in 
the next year. Specifically, never attending a late effects appointment significantly predicted a 
survivors likelihood in participating in a late effect screening appointment in the next year b= 
3.192, x2(31)=5.18 p=.019, as did attending a late effects appointment in the last  six months 
b=5.356, x2(31) = 211.876, p <.001.Model two included the non- modifiable variables found by 
previous studies to be associated with attendance at late effects along with variables identified in 
the crosstab.  
  
  59 
Table 5. Odds Ratio for Model Two - Research Supported Non-modifiable Variables  
 
 
  B (SE) OR (95%CI) 
Intercept 4(3.75) 0.02(-3.14-12.60) 
Demographic Variables 
  Age -0.14(0.12) 1.15(-0.44-0.90) 
Gender   
Male   
Female -0.84(1.12) 2.32(-3.31-1.30) 
Race   
Non-White 
  White -0.46(1.12) 0.63(-2.97-1.61) 
Income   
Prefer not to answer   
Under $20,000 2.37(1.87) 0.09(-.98-8.42) 
$20,000 to$49,999 -1.11(1.21) 3.03(-3.82-1.26) 
$50,000 to $74,999 -0.47(1.24) 1.60(-2.97-1.61) 
$75,000 to $99,999 -2.25(1.32) 9.49(-5.07-0.17) 
$100,000 or more -2.76(1.45) 15.80(-6.06- -0.73)* 
Treatment Variables    
Diagnosis   
Other   
Leukemia 0.66(1.08) 0.52(-1.47-2.79) 
Lymphoma -1.12(1.11) 3.06(-3.43-0.98) 
Bone or Soft Tissue 1.02(1.20) 0.36(-1.17-3.52) 
Central Nervous System 0.08(1.51) 0.92(-2.72-3.14) 
Neuroblastoma -0.60(1.62) 1.82(-4.29-2.62) 
Time Since Last Late Effects Appointment   
Never Attend   
Less than 6 months ago 2.96(1.37) 0.05(0.57-6.00)* 
    More than 6 months but less than a year 6.30(2.01) 0.00(2.80-12.10)** 
More than one year 1.62(1.34) 0.20(-0.81-4.31) 
More than two years 1.20(1.53) 0.30(-1.59-4.29) 
More than five years -1.51(1.79) 4.54(-7.80-1.52) 
B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*, p<.001** 
 
In model two, time since last late effects appointment was a significant predictor of a 
childhood cancer survivors’ likelihood to participate in a late effects screening appointment in 
the next year. Specifically, never attending a late effects appointment significantly predicted a 
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survivors likelihood in participating in a late effect screening appointment in the next year b= 
2.96, x2(18)=6.04 p=.014, as did attending a late effects appointment in the last six months 
b=6.30, x2(18) = 16.09, p <.000. Income, $100,000 or more, was also a significant predictor of a 
survivor’s likelihood to participate in a late effects screening appointment in the next year b=-
2.76, x2 (18)=4.06, p=.04. 
Model 3 included the non-modifiable variables found to be significant in Model 2 as well 
as all six constructs of the Health Belief Model. Self-Efficacy was the only variable associated 
with a survivor’s likelihood of participating in a late effects screening appointment in the net 
year  b=.18, x2 (16) = 4.06, p=.044. The Odds Ratio tells us that as a survivor’s self-efficacy 
increases by one unit the change in the odds of going to a late effects appointment in the next 
year is 1.2, a participant is more likely to going to a late effects screening appointment if they 
have a higher self-efficacy. 
Table 6. Odds Ratio for Model Three - Non-modifiable Variables with HBM Constructs 
 




Non-Modifiable Demographic Variables    
Income    
Prefer not to answer    
Under $20,000 0.207(1.39) 0.13	 (-1.38-13.47)	
$20,000 to$49,999 -0.39(1.18)   
$50,000 to $74,999 0.21(1.39) 0.81 (-2.77-3.35) 
$75,000 to $99,999 -2.26(1.36) 9.61 (-5.37-0.19) 
$100,000 or more -0.86(1.56) 2.35 (-4.18-2.36) 
Time Since Last Late Effects Appointment    
Never Attend    
Less than 6 months ago 1.56(1.62) 0.21 (-1.71-10.66) 
More than 6 months but less than a year 3.61(2.06) 0.03 (-0.34-13.61)* 
More than one year 0.47(1.74) 0.62 (-3.26-9.71) 
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Table 6. Odds Ratio for Model Three - Non-modifiable Variables with HBM Constructs 
(continued) 
 	 B (SE) OR  (95%CI) 
More than two years 0.25(1.60) 0.78 (-3.25-10.85) 
More than five years -3.42(2.20) 30.48 (-11.24-0.66) 
Health Belief Models Modifiable Variables   
Perceived Susceptibility 0.03(0.15) 0.97 (-0.43-0.38) 
Perceived Severity 0.23(0.14) 0.79 (-0.07-0.83) 
Perceived Benefits 0.04(.14)	 0.96 (-0.25-0.43) 
Perceived Barriers 0.03(0.08) 0.97 (-0.16-0.20) 
Self Efficacy 0.18(0.09) 0.83 (0.00-0.48)* 
Cues to Action -0.04(0.10) 1.03 (-0.25-0.19) 
B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*. 
 
An additional model, Model Four, was also assessed. It included the significant non-
modifiable variables from Model Two, and the four constructs of Champion’s Health Belief 
Model (Perceived Threat, Perception of Behavior, Cues to Action and Self-Efficacy). Three 
variables were associated with a survivors likelihood of attending a late effects appointment in 
the next year, attending a late effect appointment in the last six-months b=4.12, x2(14) = 4.80, 
p=.028; Perceived Threat, b=.14, x2 (14) = 4.08, p=.043; and Self-Efficacy b =.162, x2 (14) 
=.024, p =.029. 
Table 7. Odds Ratio for Model Four - Research Supported Non-modifiable Variables 
 
 
  B (SE) OR (95%CI) 
Intercept -11.19(4.78) 72258.12 
(-25.31- -
2.62) 
Non-Modifiable Demographic Variables   
Income    
Prefer not to answer    
Under $20,000 2.66(1.81) 0.07 (-0.84-11.55) 
$20,000 to$49,999 -0.58(1.15) 1.78 (-3.25-1.55) 
$50,000 to $74,999 0.12(1.38) 0.89 (-2.79-2.97) 
$75,000 to $99,999 -2.18(1.35) 8.83 (-5.12-0.24) 
$100,000 or more -0.98(1.54) 2.67 (-4.20-2.22) 
  62 
Time Since Last Late Effects Appointment    




  B (SE) OR (95%CI) 
 
Never Attend    
Less than 6 months ago 2.04(1.54) 0.13 (-0.95-10.00) 
More than 6 months but less than a year 4.12(2.01) 0.02 (0.38-13.52)* 
More than one year 0.9(1.60) 0.41 (-2.40-8.37) 
More than two years 0.65(1.58) 0.52 (-2.53-8.39) 
More than five years -2.89(2.07) 18.01 (-8.75-0.83) 
Health Belief Models Constructs 
   Perception of Behavior 0.14(0.07) 0.87 (0.00-0.33) 
Perceived Threat -0.02(0.06) 1.02 (-0.18-0.11)* 
Self Efficacy 0.16(0.08) 0.85 (0.02-0.36)* 
Cues to Action -0.02(0.10) 1.02 (-0.24-0.22) 
B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*. 
 
Phase Two: Qualitative Data Analysis 
After completing the online interview participants could self select to participate in a 
follow-up phone interview. Of the 92 eligible participants 40 provided contact information. All 
of the 40 potential participants were e-mailed up to three times to schedule an interview. If a 
participant did not respond to the three e-mails to schedule an interview, or if the participant 
scheduled an interview and after three phone call attempts with a follow-up e-mail and there was 
no response the participant was considered to self select out of the phone interview.  A total of 
28 (70%) phone interviews were completed. Both the demographic and treatment related non-
modifiable factors were analyzed using descriptive statistics. A grounded theory approach was 
used to code and identify themes within the five questions pertaining to late effects screening 
behaviors. 
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Description of the Phone Interview Sample 
 A total of 28 phone interviews were completed and a majority of the participants were 
female (n=16, 76.2%), Caucasian (n=16, 76.2%), had a bachelor’s degree or higher (n= 18, 
64.3%) or were employed full time (n= 18, 64.3%). Descriptive statistics of non-modifiable 
variables related to diagnosis and treatment were analyzed for phone interview participants as 
well. Leukemia (n=6, 28.6%), Lymphoma (n=4, 19.0%), and Ewing’s Sarcoma (n=4, 19.0%) 
comprise the majority of cancer diagnoses (n=14, 66.7%) of the participants in the phone 
interview. Similar to the quantitative sample, a majority of phone interview participants were not 
diagnosed with a secondary cancer or experience a relapse (n=18, 85.7%). There was a 
significant difference in the amount of time since last late affect appointment and attendance at a 
late effects appointment (p<.001). 
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Not Attend Appointment 
(N=28) (n =14) 
Characteristic Frequency % Frequency % Frequency % p-value 
Age (Mean, SD) 
       Age at Diagnosis 10.6 5.1 11.4 5.5 9.8 4.9 .419 
Years Since Treatment 13.2 5.5 12.6 6.6 13.8 4.4 .594 
Age at Survey 25.8 3.4 25.4 3.4 26.1 3.4 .545 
Insurance Age       .500 
<26 9 32.1 5 55.6 4 44.4  
≥ 26 19 67.9 9 47.4 10 52.6  
Sex 
       Female 23 82.1 13 56.5 10 43.5 .163 
Male 5 17.9 1 20 4 80 
 Race 
       White 25 89.3 12 48 13 52 .500 
Non-White 3 10.7 2 66.7 1 33.3 
 Marital Status 
       Married 11 39.3 6 54.5 5 45.5 
 Not Married 17 60.7 8 47.1 9 52.9 
 Education Level 
      
.347 
Bachelor's or higher 18 64.3 10 55.6 8 44.4 
 Non-graduate 10 35.7 4 40 6 60 
 Employment Status 
      
.653 
Employed 18 64.3 9 
 
9 
  Unemployed 10 35.7 5 
 
5 
  Diagnosis 
      
.691 
Leukemia 9 32.1 4 44.4 5 55.6 
 Lymphoma 5 17.9 4 80 1 20 
 Bone of Soft Tissue 6 21.4 3 50 3 50 
 Central Nervous 
System 2 7.1 0 0 2 100 
 Neuroblastoma 2 7.1 1 50 1 50 
 Other 4 14.3 2 50 2 50 
 Time Since Appointment 
      
<.001** 
Never Attended 3 10.7 3 100 0 0 
 Less than a year 14 50 13 92.9 1 7.1 
 More than a year 5 17.9 1 20 4 80 
 More than two years 4 14.3 0 0 4 100 
 More than five years 2 0 0 0 2 100 
 Note: Comparisons used Chi-square, Fischer’s Exact appropriate to the level of measurement. p<.05* , p <.01** 
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Five open-ended questions were asked of each participant: 1-‘What comes to mind when 
you think about late effects?’ 2 - ‘How do you think late effects impact your life?’ 3 -‘What 
influences your decision on whether or not to make an appointment to screen for late effects?’; 4 
-‘What things influence your decision to attend an appointment to screen for late effects?’; 5 - 
“Do you have any additional thoughts or comments about screening for late effects. Each 
participant has as much time as they would like to respond. A final opportunity was given to 
each survivor to express any thoughts, feelings, opinions, or concerns about late effects, 
screening, appointments or anything else related that they wanted to. If the research was able to 
provide resources for the participants, a follow-up email with resources tailored to the survivor’s 
expressed need was sent.  
Coding was done in three rounds. In the first round the researcher read through each 
interview individually and coded the responses in each interview. In round two, interview 
transcriptions were then segmented by question and a second round of coding was conducted in 
which themes or phrases that appeared were also coded. In round three, when codes appeared 
similar, the content of the coded segment was reviewed again to see if the codes were similar 
enough to be combined under a new code or needed to remain separate. The final list of codes 
was reviewed and compared against questions in Champion’s Health Belief Model Scale, the 
constructs of the HBM, constructs of the Social Cognitive Theory and Theory of Planned 
Behavior. The final list of codes closely aligned with the constructs of the HBM as well as 




  66 
Perceived Susceptibility  
 
Survivors expressed their concern about specific health issues based on their diagnosis 
and treatment plan. Their concern for these issues exemplifies their perceived susceptibility of 
developing a late effect (Table 8.). 












Likely to get a 
late effect 
 
Oh, what would make me do it right away would 
be the level of discomfort I am in or my level of 
concern for what is going on if its something new 
that I have never had to deal with before it usually 
something I try to get in to see my regular doctors 
right away about.” 
 
“a current symptom that I’m having that I really 




getting a late 
effect is great 
 
Interviewee 6: “Right now I’m dealing with late 
effects of some jaws and sinus issues of late effects 
and I have had to have for the past three years 
multiple very intensive surgeries um to deal with 
the impacts my cancer had on me, even though it’s 
not the tumor that I am having to treat. Um But its 
definitely I’ve been learning to share that late 
effects are going to be following me for the rest of 
my life, uh weather I want to or not and with each 
new season of life I’m going to have more late 
effects pop up probably.” 
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Perceived Severity 
The perceived severity of late effects is a survivor’s assessment of the impact a late effect 
may have on their current and future health. Table 9. outlines the most common concerns 
regarding the severity of future late effects. Heart issues are of the utmost concern to survivors of 
this study.  








 Interviewee 7:“ There’s been a lot of some big impact and small 
impact some of it’s been for a long time there was a lot of fear, 
um cause I just didn’t know what to expect.... 
 
“...It’s probably not the best decision but there’s definitely an 
aversion to the word oncologist as fabulous as mine was, finding 
a new doctor is scary and then having those yearly appointments 
is scary and kind of puts that knot in your stomach which 




Interviewee 10: “Um I think specifically for my chemo and 
cancer diagnosis a lot of heart things come to mind ‘cause that’s 
what’s been told to me, or secondary cancers from chemo.” 
 
Interviewee11: “we talk about the possibility of heart failure 
which is the number one I guess side effect of the chemotherapy 
I took is congestive hear failure” 
 
Interviewee 15: “Um. heart failure for me.” 
 
Interviewee 17: “Um. heart problems.” 
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Perceived Benefits  
A survivor’s perception of the benefits to screening for late effects includes their beliefs 
on the effectiveness late effects screening appointment have on reducing the threat and or 
impact having a late effect will have on their health and life. Participants expressed that it was 
better to know what was going on so that they could begin addressing the health issue, 
suggesting that they perceived a benefit to participating in screening for late effects.  









Interviewee 4: “I know that I need to go even if I don’t want to 
go, because I need to make sure that nothing else is wrong with 
me and it’s kind of just for my own peace of mind. Because if I 
don’t go I don’t know what is happening inside my body.” 
Find a late 
effects earlier 
 
Interviewee 1: “my longevity of my life, um my quality of life, 
and my family, spending time with them motivates me. um…. 
and… just fear of something popping up and um not catching it 
as early as I can.” 
 
Interviewee 6: “Um and I think that especially for me as a 
young adult now um it was a hard reality that I had to face, that 
late effects came with the package that I wasn’t aware of at the 
beginning um and so it does suck, but I think its important uh 
because you know I think as a survivor I’ve already survived 
cancer and I don’t want to let a late effect to be the thing to ail 
me more um so its important to stay on top of late effects and 
um just like with cancer they don’t define your life but they’re 
important to take care of.” 
 
Interviewee 7: “Um just ‘cause I’d rather get out in front of it, 
at the end of the day than not be aware if there’s an issues.” 
Late Effects 
appointment 
best way to find 
a late effects 
 
Interviewee 1: “um but the fear of the late effects occurring 
overpowers the barriers.” 
 
Interviewee 5: ”Um answers and hopefully a solution to the 
pain and discomfort that I feel from the late effects.” 
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Perceived Barriers 
 For young adult survivors, barriers are not just limited to their perceptions of barriers but 
also encompass physical, logistic, and financial barriers to participating in late effects screening 
appointments. 










 Interviewee 9: “And sometimes doing that’s hard because it’s so 
expensive but you just can’t live any other way.” 
Continuity of 
Care 
 Interviewee 21: “...and so since I’ve been moving around since college 









Interviewee 21: “Um I guess like my it’s a couple factors and so like I 
haven’t been very comfortable with my pediatric oncologist... and I don’t 
have a lot of trust for doctors and it take a lot of time for me to build 
trust.... but I would say it is more along the lines of distrust for health care 
professionals in general.” 
 
Interviewee 22: “I’m often met with responses like you don’t have cancer 
you’re fine. Like we’ll check to see if you have skin cancer but you don’t 
so calm the fxxx down you’re over reacting.” 
Fear/Anxiety 
 
Interviewee 7:“It’s probably not the best decision but there’s definitely an 
aversion to the word oncologist as fabulous as mine was, finding a new 
doctor is scary and then having those yearly appointments is scary and 
kind of puts that knot in your stomach which probably isn’t the best 









things to do  
 Interviewee 1: “And then sometimes some barriers for making them can 
be um just time constraints, um being too busy, sometimes its also just 
because I get nervous...” 
 
Interviewee 3: “So having to go to all the appointments there are times 
when if they tell me to go to a breathing appointment I know there’s no 
changes so I don’t go. So it’s more or less we’re all willing to go get our 
blood work and do our yearly screenings that are like the important ones 
but some of the ones that are a little less important ones sometimes don’t 
happen because of time off of work, finances, you know all the things that 
can impact you from having access to some of that even just you know 
where your appointment is located makes it difficult sometimes.” 
     
Interviewee7: “Um to screen and to check in and it was really distributive 
to be away at college I mean it’s an awful thing to complain about like 
you’re cancer free and you’re complaining about going to monthly doctors 
appointments but when you’re 18 and you have better things to do 
*nervous giggle* you know um but um I guess now it’s more just a matter 
of like having to know what I should be aware of with my health.” 
 
Interviewee 15: “Convenience, whether or not I have time” 
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Cues to Action 
 Cues to action are triggers for survivors to attend a late effects appointment. The Health 
Belief Model Scale focused on general health domains, such a healthy lifestyle and diet, but 
participants of the phone interview identify more concrete external cues, including family 
involvement and concerns about an immediate health issue (Table 12.). 








 Interviewee 1: “uh, what motivates me to make the appointment is 
uh just in order to keep my health at the most optimum level” 
Interviewee 5: ‘mainly just trying to keep myself healthy um and 
to also help others who may be going through the same situation.” 
Interviewee 6 “Um, well I do follow the rule of going every year, 
um typically.” 
 
I eat well 
balanced 
meals 
 Interviewee 14: “Um I definitely, have be a lot more careful with 
things um or I should be more careful with things like diet and 










Interviewee 4: “I see my primary care doctor every year for 
routine check ups so I know that if I have any concerns about 
potential late effects I can talk to her and that she would then be in 
contact with my oncologist. Um but I think that just because of the 
reassurance from my oncologist that um while its important you 
know to be getting routine health care um she doesn’t expect 
really any new late effects to pop up now.” 
 
Interviewee 20: “Um well I have always maintained the mindset 







Interviewee 7: “Um, if, so if I go out of my way to make the 
appointment, I’ve kind of committed myself to go and so I will go 





 Interviewee 10:  “Um my mother makes me *giggles*”  
 
Interviewee 14: “My parents they’re always pushing me to set up 
my appointment cause I don’t like going to late effects 
appointments cause there’s always something new.” 
 
Interviewee 19: “Uh they [Oncology office] actually, they keep 
up, they call me each just to remind me that I need to get my 
appointments in.” 
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Self-Efficacy 
 In the context of the study, a survivor’s self-efficacy is their confidence in their ability to 
make an appointment to screen for late effects. This included domains from feeling comfortable 
talking with providers to knowing where and how to screen for late effects.  







Know how to 
find a place to 
screen for late 
effects 
 
Interviewee 2: “on I don’t actually know of a 
clinic near me that does late effect screening 
specifically...So that’s why I haven’t ever done 
one, because I don’t know where to go or who 
to talk to.” 
 
Interviewee 6: “Um I, having just moved I’m 
actually going to be looking this summer for a 
um primary care physicians who specializes in 
oncology so that I can find somewhere to go to 
late effects appointments here. Um my new 
town but um I think once a year and then um 















Interviewee 8: “I feel very comfortable with and 
it’s very easy for me to make an appointment 
with them and work with my school schedule.” 
 
 
The factors that influence phone interview participants to attend a screening appointment 
are closely related to the constructs of the HBM and it is apparent that once an appointment is 
made to attend a late effects screening appointment survivors have stated they will attend the 
appointment. Knowing this can play a role in how health care providers design messaging 
around scheduling and attending late effects screening appointments.  
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Chapter Summary 
This study recruited 92 eligible participants to complete phase one of this study, an 
adapted version of the Health Belief Model Scale. Demographic data demonstrated that the 
sample was pulled from a wide range of ages and diagnoses. However, the majority of 
participants in both the online survey and the phone interview were white females, and an 
overwhelming majority of phone interview participants had at least a four-year college degree. 
While the quantitative portion in Phase One did not result in a model that included modifiable 
and non-modifiable variables, the qualitative results from Phase Two provided insight into young 
adult survivors of childhood cancer’s thoughts and beliefs around late effects and screening for 
them.
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CHAPTER V 
DISCUSSION AND CONCLUSION 
 
In this two-phased mixed methods study, a modified version of Champion’s Health 
Belief Model Scale was used to assess the health beliefs of young adult survivors of childhood 
cancer and a series of open-ended question phone interviews were completed to further 
understand the health beliefs and needs of young adult survivors of childhood cancer. 
Measurement Tool 
 Champion’s Health Belief Model has been utilized among numerous populations and 
translated in multiple languages and found valid and reliable. While testing and validating the 
modified version of Champion’s Health Belief Model Scale was not a focus of this study, the 
scores of each subscale and measures of central tendency were computed and compared to those 
of previous studies. Two studies reported the range of scores and measures of central tendency 
(mean and standard deviation) Pirzadeh (2018) and Umeh (2001). The mean and standard 
deviations of this study were similar to those of Pirzadeh (2018). The Pirazadeh (2018) study 
was conducted among Iranian women age 18-44 and assessed participation in breast self-exams 
and the Umeh (2001) study assed self –breast exam behaviors of British women18-35 year old.  
The scores of the subscales in this study are most similar to those of the Pirzadeh (2018) study. 
While this does not prove the validity of the adapted scale for young adult survivors of childhood 
cancer, it suggests that the scale is similar to those that are valid and reliable in other 
populations. 
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Table 15. Comparison of Study Scores to other Health Belief Model Scale Scores 
 
 











Perceived Susceptibility 3 11.93(2.78) 12.73(3.10) 8.37(2.43) 
Perceived Severity 7 23.01(4.86) 34.74(7.45) 23.83(4.65) 
Perceived Benefits 5 18.67(3.92) 13.12(1.6) 20.56(3.86) 
Perceived Barriers 10 24.15(8.28) 15.14(5.16) 23.37(4.87) 
Self Efficacy 7 41.13(6.70) -- -- 
Cues To Action 10 27.88(3.79) -- 24.73(8.78) 
Notes: M, Mean; SD, Standard Deviation. 
 
Interpretation of Research Questions One and Two 
 Three variables, Age at Time of the Survey, Insurance Age, and Time Since Last Late 
Effect appointment were identified as non-modifiable variables related to a young adult survivor 
of childhood cancer’s intent to participate in a late effect screening appointment in the next year. 
Age of the survivor has been found to be associated with a survivor’s likelihood to participate in 
late effects by previous researchers, with younger survivors more likely to attend a late effect 
(Oeffinger et. al., 2004; Arvidson, et. al., 2006; Michel, et. al., 2010).  In the United States, 
young adults are allowed to stay on their parents’ health insurance until the age of 25; at 26 they 
must obtain their own insurance. Insurance Age (whether a survivor was less than 26, or 26 and 
older) was associated with a survivor’s participation in late effects screening. This may suggest 
that this age break is an important factor, whether it is because parents are influential to younger 
survivors screening practices, survivors are able to still see their pediatric provider until the age, 
or another reason cannot be concluded from this study, but provides guidance for future research.   
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In addition, four different models were tested to identify the non-modifiable variables and 
modifiable variables that may be associated with young adult survivors of childhood cancer’s 
participation in late effects screening. Model 1 assessed all of the non-modifiable variables from 
the online survey and only Time Since Last Late Effects was found to be a significant predictor 
of a survivor’s intent to attend a late effects appointment, specifically if a survivor had attended 
an appointment in the last 6 months (p=. 019) or last year (p<.001).  Levels within this variable 
were also significantly associated with attendance (less than six months, p= .014 and More than 
6 months and less than a year, (p<.001) in Model 2 which tested both variables from previous 
studies, and those identified in the crosstab of this study. During the Qualitative portion of the 
study participants mentioned that when they attended a late effects appointment they would 
either schedule their next appointment, or their physicians would follow-up with phone calls to 
schedule an appointment. Survivors also mentioned in the qualitative portion of the study that 
they felt like a late effects screening appointment was like a yearly check-up or something that 
they should do regularly. This might suggest an area for further research into reframing late 
effects appointments as part of a survivor’s annual physical or further understanding into 
survivors’ general perceptions and beliefs of health behaviors.  
The two variables that were significant in Model Two were household incomes of 
$100,000 or more (p =.044) and Time Since Last Late Effect Appointment (less than six month 
p=.014, more than six months but less than a year, p<.001). However, when these non-
modifiable variables were included with the modifiable variables from the Health Belief Model 
Scale in Model 3, only the HBM construct of Self-Efficacy was associated with a survivor’s 
intent to attend a late effects screening appointment (p=.04). Model 4 assessed the constructs of 
Champions’ Health Belief Model Scale.  Self-efficacy was a significant contributor to Model 3, 
  76 
other studies have also found self-efficacy to be contributing factor to cancer survivors, 
screening practices (Kadan-Lottick et. al, 2002; Byrne, Lewis, Halamek, Connelly, & Mulvihill, 
1989; Leung, Wong, & Chan, 2014). Young adult survivors of childhood cancer are going 
through many transitions in their life from moves to job and insurance changes.  
Interpretation of Research Question Three 
 While the full theoretical framework of the HBM was found to not be a good fit in Phase 
One, the coded responses from individual interviews in Phase Two provided by young adult 
survivors of childhood cancer corresponded to the constructs of the HBM. In Phase One, each 
construct of the HBM was assessed by a subscale within the survey. While all six of the 
constructs were present in survivor’s responses, not all of the themes within each subscale were 
discussed (e.g. Perceived Susceptibility was comprised of three themed questions 1- likely to get 
a late effect, 2- chance of getting a late effect are great, 3- develop a late effect in the future). 
Additionally, themes specific to young adult cancer survivors’ experiences arose, which 
corresponded with the constructs of the model. A revision to the modified Health Belief Model 
Scale that reflects the beliefs of this specific population could more accurately assess young adult 
survivors of childhood cancer health beliefs as they related to late effects screening. 
Of note, was the number of survivors who expressed that they did not know about late 
effects and their severity, prevalence, or that they should be screening specifically for them. This 
is consistent with other studies that have found pediatric cancer survivors are not able to recall 
treatment or the medications they received (Byrne, Lewis, Halamek, Connelly, & Mulvihill, 
1989; Kadan-Lottick et. al, 2002). This lack of knowledge could be a potential moderating 
variable that was not measured or assessed in Phase One of the study either as a non-modifiable 
variable or within the modified version of Champion’s Health Belief Model Scale.  Figure 5. 
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diagrams the  HBM and the representative explanatory quotes from the structured phone 
interviews during Phase Two of the study. 























Figure 5. Theoretical Model with Explanatory Quotes
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Limitations and Strengths of the Study 
As with all research, this study had its limitation. Recruitment of a large enough sample 
size was a significant limitation. Research has supported using social media as an effective 
approach for recruiting survey participants. However, this did not prove to be the case for this 
study even after adding an incentive for participants. In addition, selection bias may have 
occurred since participants self-selected to participate. Survivors who are more invested in their 
treatment protocol or have concerns about potential late effects may be actively seeking 
information and may have been more willing to participate in a survey related to late effects. The 
strength of this technique is that it provided a sample of participants from across the United 
States from different geographic locations that limited the influence of a particular clinic’s 
approach to late effects screening.  
The nonrandom sampling method has the potential for internal and external threats to 
validity. The results may not be generalizable to the large population of survivors if those who 
self-select to participate are not representative of the larger population. While not a nationally 
representative sample of young adult survivors of childhood cancer the sampling method did 
allow for the inclusion of participants from across the United States. Additionally, the recoding 
of the outcome variable from six to five levels, specifically reducing the “Less than 6”six months 
ago “and “More than 6 months but less than a year ago” categories to “Less than a year ago” 
may have influenced statistical association of time since last late effect appointment and the 
outcome of young adult survivor of childhood cancer’s intent to participate in a late effect 
screening appointment in the next year. 
Unintended bias is another limitation of studies conducted using grounded theory. While 
researchers should be as unbiased as possible when interpreting the results, it is almost 
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impossible to completely separate the researchers’ knowledge or perception of data especially 
when attempting to interpret an arising theory. Starting with the HBM as a theoretical framework 
for the Phase One of the study could have influenced coding. A strength of the study, intended to 
address this limitation was the incorporation of an outside reviewer, who works with pediatric 
cancer survivors. The outside reviewer read through a selected number of interviews and 
developed codes independently of the researcher. Codes for the selected interviews were 
compared for reliability.  
   
Implications 
Policy implications.  There are a number of policy implications that arose from this 
study.  At the national level, legislative changes should be made to the Patient Protection and 
Affordable Care Act to require insurance companies to cover the cost of screening for late 
effects. During Phase Two of the study, survivors reported that the lack of coverage by their 
insurance for tests needed to screen for late effects was one of the barriers to their participation 
in late effects screening. The Patient Protection and Affordable Care Act (2010) required 
insurance companies to cover the cost of certain screening and preventative measures to include 
screening for sexually transmitted infection, colorectal cancer for those over 50, cholesterol, 
Type II Diabetes, blood pressure, and more. It’s projected that there will be over 500,000 
pediatric cancer survivors by 2020 (Robison and Hudson, 2014).  Incorporating late effects 
screening tests to be considered part of the required preventative care covered by insurance 
companies may not only reduce or eliminate this as a barrier for survivors but it may also reduce 
the financial strain on survivors. This policy change may also enable the detection and treatment 
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of late effects at an earlier stage with a potentially lower cost to both the survivor and insurance 
companies.  
 At a more regional and local level, institutional policies could be established between 
healthcare facilities that would not only provide education about late effects to survivors but also 
establish a network of primary care physicians’ knowledgeable about late effects that survivors 
could transition to directly after aging out of pediatric care. In addition, changes to physician 
training could be instrumental for survivors. Currently, continuing education units are available 
to providers if they’re at a conference that offers the course or choose to participate (Meacham, 
Lillian, Edwards, Cherven, Palgon, et al., 2017). This only reaches a limited audience of 
physicians. However, if a section of one medical course was required as part of all medical 
training on the need for late effects screening for physicians, nurses, and physicians assistants, 
then medical providers would at least be aware of these needs.   
 In addition, the development of a universal transition program that addresses the 
informational needs of survivors along with targeting their health beliefs could help to ensure 
survivors are adhering to screen guidelines and detecting late effects earlier. Pediatric cancer 
survivors who develop breast cancer are at a higher risk of mortality compared to the general 
population (Moskowitz, Chou, Neglia, Partridge, Howell, Diller, et. al., 2019).  
With proper screening earlier detection may decrease mortality rates. Participants of this study 
mentioned their need to adhere to a better diet and physical activities which coincides with the 
high rate of obesity among childhood cancer survivors (Li, Beltran, Baranowski, Thompson, 
Chandra, &Baranowski, 2013). Development of a program that address the informational needs 
of survivors to include how to over come barriers could be beneficial in address the concerns 
identified in Phase Two of the study. Promotion of healthy eating habits and behaviors, along 
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with screening practices could help address some of the late effects such as obesity and higher 
rates of mortality.   
Implications for Future Research. While the results of quantitative assessment in Phase 
One of the study did not support a model that included any of the non-modifiable or modifiable 
variables in a regression model, the themes identified in the structured interviews in Phase Two 
suggest that further modification of the Health Belief Model Scale may be needed for this 
specific population. Further validation and modification of Champion’s Health Belief Model 
Scale is needed. 
In addition to modifying the measurement tool, further research could and should be 
conducted among survivors outside of the targeted age group and geographic constraints. This 
would provide further insight into the health beliefs of childhood cancer survivors who have 
been even further out from treatment and are less aware of screening for late effects. Individuals 
within the social media groups who were outside the eligibility criteria noted significant 
informational needs about late effects and screening for them in response to recruitment for 
participants in the study. 
Conclusion 
 
 The purpose of this study was to assess young adult cancer survivors’ participation in late 
effects screening appointments, by identifying the non-modifiable and modifiable factors 
associated with their likelihood of attend a late effect appointment in the coming year. A mixed-
methods approach with a convenience sample was used. Prior research has focused on the 
demographic and treatment variables of a survivor and their relationship to late effects screening 
practices of childhood cancer survivors.  
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The results of this study echoed those with similar applications of Champion’s Health 
Belief Model Scale among different populations. Yet the results of the firth logistic regression 
models do not fully support the Health Belief Model as an explanatory model of young adult 
survivors of childhood cancer’s likelihood of participating in a late effects appointment.  While 
the generalizability of these results is limited, they are a starting point for developing further 
understanding of childhood cancer survivor’s health beliefs and practices as they relate to late 
effects screening from a theory based perspective.
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My chances of getting 
breast cancer are great. 
     
My physical health makes 
it more likely that I will get 
breast cancer. 
     
I feel that my chances of 
getting breast cancer in the 
future are good. 
     
There is a good possibility 
that I will get breast cancer. 
     
I worry a lot about getting 
breast cancer. 
     
Within the next year I will 
get breast cancer. 
































     
The thought of breast 
cancer scares me. 
     
When I think about breast 
cancer I feel nauseous. 
     
If I had breast cancer my 
academics and career 
would be endangered. 
     
When I think about breast 
cancer my heart beats 
faster. 

























































Breast cancer would 
endanger my significant 
relationship. 
     
Breast cancer is a hopeless 
disease. 
     
My feelings about myself 
would change if I got 
breast cancer. 
     
I am afraid to even think 
about breast cancer. 
     
My financial security 
would be endangered if I 
got breast cancer. 
     
Problems I would 
experience from breast 
cancer would last a long 
time. 
     
If I got breast cancer, it 
would be more serious than 
other diseases. 
     
If I had breast cancer, my 
whole life would change. 
































     
Doing breast self-exams 
prevents future problems 
for me. 
     
I have a lot to gain by 
doing breast self-exams. 
     
Breast self-exams can help 
me find lumps in my 
breast. 
     
If I do monthly breast 
exams I may find a lump 
before it is discovered by 
regular health exams. 
     
I would not be so anxious 
about breast cancer if I did 
monthly exams. 






































Having breast exams 
performed by a physician 
prevents future problems 
for me. 
     
I have a lot to gain by 
having breast exams 
performed by a physician. 
     
Breast exams performed by 
a physician can help me 
find lumps in my breast. 
     
If I have a breast exam 
performed by a physician 
every three years, I may 
find a lump before it is 
discovered by self breast 
exams. 
     
I would not be so anxious 
about breast cancer if I had 
a breast exam performed 
by a physician every three 
years. 
     
It is embarrassing for me to 
have a breast exam 
performed by a physician. 
































     
It is embarrassing for me to 
do monthly breast exams. 
     
In order to do monthly 
breast exams I have to give 
up quite a bit. 
     
Breast self-exams can be 
painful. 
     
Breast self-exams are time 
consuming. 
     
My family/ friends would 
make fun of me if I did 
breast self-exams. 
     
The practice of breast self- 
exams interferes with my 
activities. 




Doing breast self-exams 
would require starting a 
new habit, which is 
difficult. 
     
I am afraid I would not be 
able to do breast self- 
exams. 
     
It is embarrassing for me to 
have a breast exam 
performed by a physician. 
     
In order to have a breast 
exam performed by a 
physician every three 
years, I have to give up 
quite a bit. 
     
Breast exams performed by 
a physician can be painful. 
     
Breast exams performed by 
a physician are time 
consuming. 
     
My family/ friends would 
make fun of me if I have a 
breast exam performed by 
a physician. 
     
The practice of breast 
exams performed by a 
physician interferes with 
my activities. 
     
Having breast exams 
performed by a physician 
would require starting a 
new habit, which is 
difficult. 
     
I am afraid I would not be 
able to go to a breast exam 
performed by a physician. 
     
Having breast exams 
performed by a physician 
are expensive. 





























































     
I eat a well-balanced diet.      
I always follow medical 
orders because I believe 
they will benefit my state 
of health. 
     
I frequently do things to 
improve my health. 
     
I take vitamins when I 
don't eat good meals. 
     
I search for new 
information related to my 
health. 
     
I have the recommended 
yearly physical exams in 
addition to visits related to 
illness. 
     
I have the recommended 
periodic dental exams in 
addition to visits for a 
specific problem. 
     
I exercise regularly- at least 
three times a week. 
































     
I know how to perform a 
breast self-exam. 
     
I have performed a breast 
self-exam. 
     
I have performed a breast 
self-exam in the past year. 
     
I have performed a breast 
self-exam in the past 3 
months. 
     
 





I have performed a breast 
self-exam in the past 
month. 
     
I feel confident that if I 
perform a breast self-exam, 
I could feel any 
abnormalities in my breast. 
     
I know how to get a breast 
exam performed by a 
physician. 
     
I have had a breast exam 
performed by a physician. 
     
I have had a breast exam 
performed by a physician 
in the past year. 
     
I have had a breast exam 
performed by a physician 
in the past 2 years. 
     
I have had a breast exam 
performed by a physician 
in the past 3 years. 
     
I feel confident that if I 
have a breast exam 
performed by a physician, 
any abnormalities in my 
breast will be detected. 
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 ADAPTED VERSION OF CHAMPION’S HEALTH BELIEF MODEL SCALE 
SAMPLE COPY, DO NOT USE WITHOUT PERMISSION 
 
The following questions are related to your experiences with childhood cancer and late effects 
screening. There are no right or wrong answers and you do not have to participate in late effects 
screening to complete the survey. Please select the option that best describes your feelings about 
each statement. 
 Strongly Disagree Disagree Neutral Agree 
Strongly 
Agree 
Perceive Susceptibility      
1. It is extremely likely I will get a late 
effect. 
     
2. My chances of getting a late effect in 
the next few years is great 
     
3. I feel I will get a late effect sometime 
during my life. 
     
Perceived Severity      
4. The thought of late effects scares me.      
5. When I think about late effects, my 
heart beats fast. 
     
6. I am afraid to think about late effects.      
7. Problems I would experience with late 
effects would last a long time.  
     
8. Late effects would threaten a 
relationship with my significant other, 
partner, or spouse. 
     
9. If I had a late effect my whole life 
would change. 
     
10. If I developed late effects, I would 
not live longer than five years. 
     
Perceive Benefits      
11. When I attend an appointment to 
screen for late effects and nothing is 
found, I don't worry as much about late 
effects.  
     
12. Attending appointments for late 
effect will allow me to find late effects 
early. 
     
13. If I find a late effect at a late effect 
appointment, my treatment for the late 
effect may not be so bad. 
     
14. Attending a late effects appointment      
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is the best way for me to find a late 
effect. 
15. Attending a late effect appointment 
will decrease my chances of dying from a 
late effect. 
     
Perceived Barriers      
16. I am afraid to attend a late effects 
appointment because I might find out 
something is wrong. 
     
17. I am afraid to attend a late effects 
appointment because I don’t know what 
will happen. 
     
18. I don’t know how to get an 
appointment to screen for late effects. 
     
19. Attending an appointment to screen 
for late effects is too embarrassing. 
     
20. Attending an appointment to screen 
for late effects takes too much time.  
     
21. Attending an appointment to screen 
for late effects is too unpleasant. 
     
22.Health professions doing late effects 
screening are rude to survivors. 
     
23. Attending an appointment to screen 
for late effects exposes me to 
unnecessary radiation. 
     
24. I cannot remember to schedule an 
appointment to screen for late effects. 
     
25. I have other problems more 
important than attending an appointment 
to screen for late effects. 
     
26. I am too old to attend an 
appointment to screen for late effects. 
     
Self Efficacy      
27. I can arrange transportation to attend 
an appointment to screen for late effects. 
     
28. I can arrange other things in my life 
to attend an appointment to screen for 
late effects. 
     
29. I can talk to people at my late effects 
screening appointment location about 
my concerns. 
     
30. I can attend an appointment to screen 
for late effects even if I am worried.  
     
31. I can attend an appointment to screen 
for late effects even if I don’t know what 
to expect. 
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32. I can find a way to pay for an 
appointment to screen for late effects. 
     
33. I can make an appointment for an 
appointment to screen for late effects. 
     
34. I know for sure I can get an 
appointment for an appointment to 
screen for late effects if I really want to. 
     
35. I know how to go about getting an 
appointment for an appointment to 
screen for late effects. 
     
36. I can find a place to have an 
appointment to screen for late effects. 
     
Cues to Action      
37. I want to discover health problems 
early. 
     
38. Maintaining good health is 
extremely important to me. 
     
39. I search for new information to 
improve my health. 
     
40. I feel it is important to carry out 
activities that will improve my health. 
     
41. I eat well-balanced meals.       
42. I exercise at least three times a week.      
43. I have regular health checkups even 
when I am not sick.  
     






CONSENT AND FINAL ADAPTED VERSION OF HEALTH BELIEF MODEL SCALE 
 
Consent  
PROJECT TITLE: Understanding Childhood Cancer Survivors’ Participation in Screening for 
Late Effects: A Mixed Methods Approach. 
 
INTRODUCTION The purposes of this form is to give you information that may affect your 
decision whether to say YES or NO to participation in this research and to record the consent of 
those who say YES. Understanding Childhood Cancer Survivors’ Participation in Screening for 
Late Effects: A Mixed Methods Approach. Conducted using an online survey and self-selected 
participation in follow-up phone interview. 
 
RESEARCHERS  
Dr. Richardean Benjamin, PhD, RN, MPH, Associate Dean of the College of Health Sciences, 
Old Dominion University 
Dr. Matthew Hoch, PhD, LAT, Lecturer of Physical Therapy and Athletic Training, University 
of Kentucky 
Dr. Tina Haney DNP, CNS, RN, Assistant Professor of Nursing, Old Dominion University 
Dr. Hadiza Galadima, Assistant Professor of Biostatistics, School of Community and 
Environmental Health 
Kristen Trost Mantlo, MSS, Doctoral Candidate, Health Services Research, Old Dominion 
University  
 
DESCRIPTION OF RESEARCH STUDY 
Several studies have been conducted looking into survivors of childhood cancer’s participation in 
late effects follow-up appointments. None of them have explained survivors of childhood 
cancers’ perception about late effects on their participation in late effects follow-up 
appointments. If you decide to participate, then you will join a study involving research of 
survivors of childhood cancers’ participate in late effects screening. Using an online survey you 
will be asked questions about your thoughts on developing a late effect if certain things are 
obstacles to participating in late effects follow-up appointments, what the benefits to 
participating in late effects appointments maybe, and your level of participation in attending late 
effects follow-up appointments. If you say YES, then your participation will last for the online 
survey is expected to take 10-30 minutes and at the end, you will have the opportunity to 
volunteer to participate in a phone interview to further discuss your thoughts about late effects 
follow up appointments. This follow up interview could last between 20-60 minutes. Both the 
online survey and phone interview can take place in the location of your choosing. We have a 
target recruitment of 250 participants.   
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EXCLUSIONARY CRITERIA  
You should have completed treatment for childhood cancer at least five years ago and be 
between the ages of 18 and 29.   To the best of your knowledge, you should not have received 
any treatment for cancer within the last five years, be younger than 18 years of age, or older than 
29.   
 
RISKS AND BENEFITS 
RISKS:  If you decide to participate in this study, then you may face a risk of discomfort from 
recalling traumatic or distressing events associated with treatment, and discomfort due to loss of 
time. The researcher tried to reduce these risks by selecting a measurement tool that is been used 
with similar participants and is relatively short in length. And, as with any research, there is 
some possibility that you may be subject to risks that have not yet been identified. If at anytime 
you feel any distress and wish to speak with someone please call 1-888-793-9355, the social 
worker associated with the hospital you were treated at, or go to the link for online support 
http://www.cancersupportcommunity.org/find-support/online-support BENEFITS:  The main 
benefit to you for participating in this study is the opportunities to provide information about 
your participation in late effects follow up appointments. Others may benefit from changes made 
to educational materials and program development as a result of findings from this study. 
 
COSTS AND PAYMENTS 
The researchers are unable to give you any payment for participating in this study.  
 
NEW INFORMATION 
If the researchers find new information during this study that would reasonably change your 
decision about participating, then they will give it to you.  
 
CONFIDENTIALITY 
The researchers will take reasonable steps to keep private information, such as questionnaires 
and interview responses confidential. The researcher will remove identifiers from the 
information, and maintain all information in a password-protected file on a password-protected 
hard drive and maintain this information in a locked cabinet when not in use. The results of this 
study may be used in reports, presentations, and publications; but the researcher will not identify 
you and will take steps to remove any identifying information when reporting results.    
WITHDRAWAL PRIVILEGE  
 
It is OK for you to say NO. Even if you say YES now, you are free to say NO later, and walk 
away or withdraw from the study ‑‑ at any time.   
 
COMPENSATION FOR ILLNESS AND INJURY 
                      
If you say YES, then your consent in this document does not waive any of your legal 
rights.  However, in the event of harm arising from this study, neither Old Dominion University 
nor the researchers are able to give you any money, insurance coverage, free medical care, or any 
other compensation for such injury.  In the event that you suffer injury as a result of participation 
in any research project, you may contact Dr. Richardean Benjamin the Responsible Principle 
Investigator at 757-683-4960, Dr. Tancy Vandecar-Burdin  the current IRB chair at 757-683-
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3802 at Old Dominion University, or the Old Dominion University Office of Research at 757-
683-3460 who will be glad to review the matter with you. 
 
VOLUNTARY ELECTRONIC CONSENT  
By clicking on the “Agree” button you agree that  
· You have read the above information 
· You understand this form, the research study, and its risks and benefits 
· You voluntarily agree to participate 
· You are 18 years of age or older 
 
You may print a copy of this consent form for your records.  If you have any questions, then the 
researchers should be able to answer them: Richardean Benjamin, Ph.D. at 757-683-
4960Matthew Hoch, Ph.D. 757-683-4351Tina Haney, DNP, CNS, RN 757-683-5428Kristen 
Trost, MSS 757-576-1455 If at any time you feel pressured to participate, or if you have any 
questions about your rights or this form, then you should call Dr. Tancy Vandecar-Burdin the 
current IRB chair at 757-683-3802, or the Old Dominion University Office of Research, at 
757‑683‑3460. 
o Agree  (1)  
o Disagree  (2)  
 
Skip To: End of Survey If Consent = Disagree 
 










Q 2 Gender: 
o Male  (1)  
o Female  (2)  
o Transgender  (3)  




Q 3 Race: 
  
o African American  (1)  
o Asian/Pacific Islander  (2)  
o Hispanic/Latino  (3)  
o Multiracial  (4)  
o Native American/American Indian  (5)  
o White/Caucasian  (6)  
o Not Listed (please specify)  (7) 
________________________________________________ 






Q 4 What is the highest level of education you have completed? 
o Grammar school  (1)  
o High School or equivalent  (2)  
o Vocational/technical school  (3)  
o Some College  (4)  
o Bachelor's Degree  (5)  
o Masters Degree  (6)  
o Doctoral Degree  (7)  
o Professional Degree (JD, MD)  (8)  




Q 5 What is your marital status? 
o Single, not married or living with partner  (1)  
o Married  (2)  
o Divorced  (3)  
o Separated  (4)  
o Widowed  (5)  





Q 6 Employment status: 
o Employed for wages  (1)  
o Self-employed  (2)  
o Out of work and looking for work  (3)  
o Out of work but not currently looking for work  (4)  
o Homemaker  (5)  
o Student  (6)  
o Military  (7)  
o Retired  (8)  




Q 7 What is your current household income (in U.S. dollars)? 
o Under $10,000  (1)  
o $10,000 - $19,999  (2)  
o $20,000 - $29,000  (3)  
o $30,000 - $39,000  (4)  
o $40,000 - $49,000  (5)  
o $50,000 - $74,999  (6)  
o $75,000 - $99,999  (7)  
o $100,000 - $150,000  (8)  
o Over $150,000  (9)  




Q8 What kind of area do you reside? 
o Rural  (1)  
o Small town  (2)  
o Suburban  (3)  
o Urban  (4)  





Q 9 How is your insurance provided? 
o Through your place of employment  (1)  
o Through your spouse's or parents' policy  (2)  
o Through a policy you have purchased yourself  (3)  
o Medicaid or other public assistance program  (4)  
o Medicare  (5)  
o Military insurance/Veteran's benefits / CHAMPUS  (6)  









Q 11 What was your cancer diagnosis? 
o Leukemia (ALL)  (1)  
o Leukemia (AML)  (2)  
o Leukemia (Biphenotypic)  (3)  
o Tumor of the central nervous system (brain, spinal cord, lobe, cerebellum)  (4)  
o Hodgkin Lymphoma  (5)  
o Non-Hodgkin Lymphoma  (6)  
o Kidney Tumor  (7)  
o Neuroblastoma  (8)  
o Soft Tissue Sarcoma  (9)  
o Bone Tumor  (10)  




Q 12 At any time following your original diagnosis, were you diagnosed with another cancer, 
leukemic, tumor or similar illness (include any relapse or recurrence of his/her original 
diagnosis)? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Q 12 = Yes 
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Q 12a Was this a: 
o Recurrence of your original diagnosis  (1)  
o New cancer, leukemia, or similar illness  (2)  








Q14 When did you last attend an appointment to screen for late effects? 
o Have never attended   (1)  
o Less than 6 months ago  (2)  
o More than 6 months but less than a year  (3)  
o More than one year ago  (4)  
o More than two years ago  (5)  





Q15 How likely are you to attend an appointment within the next year to specifically screen for 
late effects? 
o Extremely likely  (1)  
o Somewhat likely  (2)  
o Neither likely nor unlikely  (3)  
o Somewhat unlikely  (4)  
o Extremely unlikely  (5)  
 
 
Page Break  
The following questions are related to your experience with childhood cancer and late effects 
screening. Late effects are defined as problems related to cancer treatment that occurs or 
continues after treatment is completed.  Screening for late effects includes attending 
appointments and performing self-checks specifically to detect potential problems that may be 
related to cancer treatment.  There are no right or wrong answers, and you do not have to 
participate in late effects screening to complete the survey. Please select the option that best 





Q16 Susceptibility  
 Strongly agree (1) Agree (2) Neutral (3) Disagree (4) 
Strongly 
disagree (5) 
It is extremely 
likely I will 
get a late 
effect. (4)  
o  o  o  o  o  
My chances of 
getting a late 
effect in the 
next few years 
is great. (5)  
o  o  o  o  o  
I feel I will get 
a late effect 
sometime 
during m life. 
(6)  






Q 17 Severity 




of late effects 
scares me. (1)  o  o  o  o  o  




fast. (2)  
o  o  o  o  o  










last a long 
time. (4)  








or spouse. (5)  
o  o  o  o  o  




change. (6)  
o  o  o  o  o  
If I developed 




years. (7)  




 Strongly agree (1) Agree (2) Neutral (3) Disagree (4) 
Strongly 
disagree (5) 
When I attend 
an 
appointment 
to screen for 
late effects 
and nothing is 














o  o  o  o  o  
If I find a late 




for the late 
effect may 
not be so bad. 
(3)  




is the best 
way for me to 
find a late 
effect. (4)  






o  o  o  o  o  
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of dying from 








 Strongly agree (1) Agree (2) Neutral (3) Disagree (4) 
Strongly 
disagree (5) 
I am afraid to 






wrong. (1)  
o  o  o  o  o  
I am afraid to 






happen. (2)  
o  o  o  o  o  
I don't know 
how to get an 
appointment 
to screen for 
late effects. 
(3)  
o  o  o  o  o  
Attending an 
appointment 
to screen for 




o  o  o  o  o  
Attending an 
appointment 





o  o  o  o  o  
Attending an 
appointment 
to screen for o  o  o  o  o  
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survivors. (7)  
o  o  o  o  o  
Attending an 
appointment 
to screen for 
late effects 
exposes me to 
unnecessary 
radiation. (8)  





to screen for 
late effects. 
(9)  
o  o  o  o  o  







screen for late 
effects. (10)  
o  o  o  o  o  
I am too old 
to attend an 
appointment 
to screen for 
late effects. 
(11)  






 Strongly agree (1) Agree (2) Neutral (3) Disagree (4) 
Strongly 
disagree (5) 
I can arrange 
transportation 
to attend an 
appointment 
to screen for 
late effects. 
(1)  
o  o  o  o  o  
I can arrange 
other things 
in my life to 
attend an 
appointment 
to screen for 
late effects. 
(2)  
o  o  o  o  o  
I can talk to 






concerns. (3)  
o  o  o  o  o  
I can attend 
an 
appointment 
to screen for 
late effects 
even if I am 
worried. (4)  
o  o  o  o  o  
I can attend 
an 
appointment 
to screen for 
late effects 
even if I don't 
know what to 
expect. (5)  
o  o  o  o  o  
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I can find a 
way to pay 
for an 
appointment 
to screen for 
late effects. 
(6)  
o  o  o  o  o  
I can make an 
appointment 
to screen for 
late effects. 
(7)  
o  o  o  o  o  
I know for 
sure I can 
make an 
appointment 
to screen for 
late effects if 
I really want 
to. (8)  
o  o  o  o  o  
I know how 
to go about 
getting an 
appointment 
to screen for 
late effects. 
(9)  
o  o  o  o  o  
I can find a 
place to have 
an 
appointment 
to screen for 
late effects. 
(10)  






Q21 Cues to Action 
 Strongly agree (1) Agree (2) Neutral (3) Disagree (4) 
Strongly 
disagree (5) 




early. (1)  
o  o  o  o  o  
Maintaining 
good health is 
extremely 
important to 
me. (2)  
o  o  o  o  o  




my health. (3)  
o  o  o  o  o  





my health. (4)  
o  o  o  o  o  
I eat well-
balanced 
meals. (5)  o  o  o  o  o  
I exercise at 
least three 
times a week. 
(6)  
o  o  o  o  o  
I have regular 
health 
checkups 
even when I 
am not sick. 
(7)  




Page Break  
 129 
Q22 Would you be willing to participate in a brief follow-up phone conversation about your 
thoughts on late effects and screening for them?  
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Q22 = No 
Q32 Please provide your e-mail if you wish to be entered into a drawing for a pair of wireless 
Beats headphones. 
 
Thank you for taking time out to participate in our survey. We truly value the information you 
have provided us. Your responses are vital in helping to understand participation in late effects 




Display This Question: 
If Q22 = Yes 
 
Q22a The next couple of questions are to collect contact information for the follow-up phone 




Display This Question: 
If If The next couple of questions are to collect contact information for the follow-up phone 
call. Please provide your fist name: Text Response Is Not Empty 





Display This Question: 
If If Please provide the phone number you wished to be reached at: Text Response Is Not 
Empty 
 




Display This Question: 
If If Please provide the phone number you wished to be reached at: Text Response Is Not 
Empty 
 
Please provide your e-mail if you wish to be entered into a drawing for a pair of wireless Beats 
headphones. 
 
Thank you for taking time out to participate in our survey. We truly value the information you 
have provided us. Your responses are vital in helping to understand participation in late effects 
screening and the development of future transition programs.  
________________________________________________________________ 
 
End of Block: Default Question Block 
 
 




APPENDIX E PHONE INTERVIEW SCRIPT 
Good Morning/ Afternoon, this is Kristen Trost, I am calling you as you opted to participate in a 
follow-up phone interview as part of a study on young adult survivors of childhood cancer’s 
participation in late effects screening. I’d like to confirm your willingness to still participate.  
 
I am first going to ask you some demographic questions, followed by some questions about you 
treatment, and followed by my last set of questions about your thoughts on late effects and 
screening for them. This should take between 20 minutes and an hour, depending on how our 
conversation goes. If at any time you feel uncomfortable or wish to stop please let me know. 
 
Are you ready to proceed? 
 
How old are you currently? 
 
Would you please define your gender for me? 
 
Female, Male, Transgender, Prefer not to answer 
 
Would you please define you race/ethnicity for me? 
 
What is the highest level of education you have completed? 
 
What is your marital status? 
 
What is your employment status? 
 
My next set of questions is about your treatment history: 
 
To the nearest year, how long has it been since you last received treatment for cancer? 
 
To the nearest year, how old where you when you were diagnosed with cancer? 
 
What was your diagnosis? 
 
At any time following your original diagnosis, were you diagnosed with another cancer, 
(leukemia, tumor, or similar illness)?      
 
When did you last attend an appointment to screen for late effects? 
 
My final set of questions is about your thought and feelings about late effects and attending 
appointments to screen for late effects.  
 
What comes to mind when you think about late effects? 
 
How do you think late effects impact your life? 
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Have you attended an appointment to screen for late effects in the past year? 
 
What influences your decision on whether or not to make an appointment to screen for late 
effects? 
 
What things influence your decision to attend an appointment to screen for late effects? 





Kristen Trost Mantlo 
Old Dominion University, College of Health Sciences 
Norfolk, VA 23529 
EDUCATION 
PhD, Health Services Research, 2019, Old Dominion University, Norfolk, VA 
MSS, Community Practice, Policy, and Advocacy, 2010 Bryn Mawr College, Bryn Mawr, PA  
BSW, Social Work, James Madison University, Dec 2008, Harrisonburg, VA 




Cramer, R. J., Golom, F. D., Gemberling, T. M., Trost, K., Lewis, R., & Wright, S. (2018). 
Examining the Lesbian, Gay, and Bisexual Identity Scale among members of an 
alternative sexuality special interest group. Archives of Sexual Behavior, 47(4), 
1251-1264. 
Bermudez, L. Trost, K.A. and Ayala, R. (2013). “Investing in a Surgical Outcomes 
Auditing System," Plastic Surgery International, Article ID 671786, 6 pages. 
doi:10.1155/2013/671786. 






Mantlo, K.T., Benjamin, R., Gustin, T., Galadima, H., and Hoch, M. (2019).  “Using Social 
Media to Recruit Millennial-Aged Survivors of Pediatric Cancer for a Mixed-Methods 
Study, Lessons Learned.” Poster Presentation, Graduate Research Assessment Day, Old 
Dominion University.  
Trost, K.A. and Neff, J. (2014). “The Role of Theory in Teen Pregnancy Prevention: A 
Review of 31 Federally Supported Evidence Based Programs.” Poster Presentation, 
Society of Public Health Educators Annual Conference. 
Ford, K.A. and Trost, K.A. (2009) “Connecting Future Generalist Practitioners to the 
Profession and NASW: What’s Missing?” Round Table Presentation, The 
Association of Baccalaureate Social Work Program Directors Annual Conference 
McKinley, K. and Trost, K.A. (2006) “I Know I’m Selfish but…”, Poster Presentation, 
Association of Pediatric Oncology Social Workers 30th Annual Conference 
AWARDS 
Community Builders Award -2019 
College of Health Sciences –Graduate Fellowship 2012-2017 
 
